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ABSTRACT 
DETECTION OF ERM GENE AMONG INDUCIBLE CLINDAMYCIN RESISTANT 
STAPHYLOCOCCAL ISOLATES IN CLINICAL SAMPLES 
BACKGROUUND OF THE STUDY: 
Staphylococcus  aureus  infection  is  associated  with  hospital  and  infections which  arise  from  
the  community . The emergence of resistance to most antimicrobial agents in Staphylococci indicates the 
need for new effective agents in the treatment of Staphylococcal infection. Among the alternatives 
available Clindamycin is considered to be safe, effective and less costly agent.In vitro routine tests for 
Clindamycin susceptibility may fail to detect inducible Clindamycin resistance due to erm genes, resulting 
in treatment failure, thus necessitating the need to detect such resistance by a simple D-test on routine 
basis.  
AIM: 
The present study is aimed to detect erm gene in inducible Clindamycin resistant Staphylococcal  
isolates and to study the relationship between Clindamycin and  Methicillin   resistance. 
MATERIALS AND METHODS: 
During  the  study  period   a  total  of  100  non  duplicate  clinical  isolates   of  Staphylococci  
were  collected  from   different  clinical  samples  like    aural  swabs,  wound  swabs, pus and  vaginal  
swabs  from  both  in-patient   and  out-patient  departments  of  Tirunelveli  Medical  College  The  
Staphylococcal  species  were  identified  by  standard   biochemical   techniques.and their antibiotic 
susceptibility tested by standard disk diffusion method on Muller Hinton agar [MHA] according to the 
standards of clinical and laboratory standards institute[CLSI].Detection of inducible Clindamycin 
resistence was  performed by D-test on a Mueller Hinton agar plate with a  lawn culture of the isolate 
which was adjusted to 0.5 Mcfarland’s concentration . Discs of Clindamycin(2µg),Erythromycin(15µg) 
were kept at a distance of 15mm. The disc diffusion D test, showed   
 Inducible MLSB phenotype (iMLSB ) 
  Constitutive MLSB phenotype (cMLSB) 
 MS phenotype 
The  Staphylococcal  isolates  from  MLSBi  were  further  tested   by  Real-Time  PCR  for  
ermA/ermB/ermC  genes.   
RESULTS:                                      
In  this  study  among  the  100  Staphylococcal  isolates  80%  were  Staphylococcus  aureus  and  
rest   20%  were  coagulase  negative staphylococcus. Out of   strains  isolated  80%  were from  
hospitalized  patients .  The  study  group  contained  55% males  and  45%  females  and  Male   to 
female  sex  ratio  was  1.2 2:1. Majority  of  the  study  group  were  found  among  the  age  group  21-30 
yrs. 
Majority  of  the  Staphylococcal aureus   75%   and CONS   100%   were  isolated  from  pus  
and  majority  of  the  MSSA 76.36%  and  72% MRSA were    also  from  pus.   Inducible  MLSB  
resistance  was   detected  by  Disc  diffusion  test ( D-test).  
In  D-test   the  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  were  35%, 12.5%  and 
52.5%  respectively.  In  the  phenotypic  distribution  of  iMLSB  Staphylococcus .aureus  was  37.5%   
and  CONS     25%,.   MSSA  31.58%  and     MRSA 46.15%.  
Majority  of  the  iMLSB  was  susceptible  to  Ciprofloxacin  ,Cotrimoxazole  and   Gentamycin. 
while  cMLSB  and  MS  phenotype  were  resistant  to  ciprofloxacin when  compaired  to  iMLSB .There 
was  high  rate  of  resistance  exhibited  by  cMLSB towards  Cefoxitin  when  compaired  to  iMLSB. No 
resistance was observed to vancomycin. 
Genetic  analysis  by   real  time  PCR  performed  on  iMLSB   showed  21.42% erm A,7.14% 
erm B,14.3% erm C,50% erm A and  erm C  and  7.14% erm B  and  erm C.  
CONCLUSION: 
In  this  present  study    D-test is easy to perform and  found  inexpensive for practical purpose 
than PCR  which  is  the  gold  standard .This test is  used to detect an inducible Clindamycin resistance in 
staphylococci as a routine work in clinical microbiology laboratories. This test help us  to provide 
confident  laboratory reports and Clindamycin can be omitted in patients with infections caused  by 
inducible Clindamycin  resistance staphylococci, and therapeutic failures may be thus avoided. 
Key words: Staphylococcus aureus, Coagulase  Negative Staphylococcus, Inducible MLSB phenotype 
(iMLSB ), erm A, erm B  and  erm C genes. 
. 
1 
1.  INTRODUCTION 
 
Staphylococcus  aureus  infection  is  associated  with  hospital  and  
infections which  arise  from  the  community   .  Staphylococci   mainly   
colonizes  various  skin   and  mucosal surfaces. Infections occur   due   to  
trauma   or  abrasion  to   these  surfaces.  Person  to  person  spread  of    
Staphylococci   gets established as part of normal flora of the recipient or 
produces  infection  on  introduction  to  sterile  sites  during  surgery.   
Staphylococci   produces   a  wide  spectrum  of  infections. Several  
toxins  and  enzymes  are  produced  by  Staphylococci  that  cause  tissue 
invasion  and  survival  of  the  organism  resulting  in  life  threatening  
infections. 
Most   of  the Staphylococci causing serious  nosocomial infections 
have acquired antimicrobial resistance. The rising level of resistance has 
been found in Staphylococcus  aureus  and  Coagulase  Negative  
Staphylococcus  (CONS)  to  a wide  range  of  antibiotics . This has  lead  to  
significant  threat  in  the  treatment  efficacy  of  both  Staphyloccus  aureus  
and  Coagulase  Negative  Staphylococcus (CONS). 
1
 
Healthy children are common  carrier  of  Staphylococci. Individuals   
who  are  nasal  carriers  may  develop  clinical  infection .  The emergence  
2 
of  Methicillin  resistant  Staphylococcus  aureus  (MRSA)  has  become  a  
notorious  hospital  acquired   infection . In  early  1940s  Penicillin   was  
introduced and  shortly   resistance    to  Penicillin  group  of  antibiotics  
began emerging . 
Resistance  arised  due  to  the  production  of  enzyme   β-lactamase  
that  hydrolyzed  the   ring  present  the  β-lactam antibiotics.  The  genes  
that  are  responsible for  this  resistance  are  found  on  class  II   plasmid 
2 
 
Methicillin  was  introduced  in  Britain  for  clinical  use  and  soon resistant  
strains  developed  against  other  β-lactamase-resistant  Penicillins  and  to   
Methicillin.   Today  75-95  percent  Penicillin-resistant  strains  has  been 
recognized  with  the  maximum  being  reported  among  hospital  isolates.             
In recent  days  there is a  rise  in    resistance for  Methicillin.  
MRSA  strain  was  first  isolated  in  1982,  and  intermediate  
resistant  MRSA  strain to  Vancomycin  (Mu50)  was identified  in  1997.
3
 
MRSA  resulted   in  a  wide  variety  of suppurative  infections  including  
abscesses,  exudative  dermatitis,  severe pyoderma,  fistulas  and  
postoperative  wound  infections. Methicillin resistance  has  become an  
increasing problem  as resistance  to other antimicrobial agents occur   in  
MRSA  
4
  
The  utility  of  older  antimicrobials  like Trimethopriim     
Sulfamethoxazole  and  Clindamycin was  encouraged  due  to  the  
3 
emergence of  Methicillin resistance .This  raised  an  interest  to use   
Macrolide-Lincosamide-Streptogramin B (MLSB) antibiotics  to  correct   
Staphylococcal  infections.                                                
It is not advisible to treat  empirically   Staphylococcal  infection  due  
to  the  rise  of  multi  drug  resistance  among   MRSA. Clindamycin   has  
been  an  better  option  due  to  good  tissue  penetration  of  all   tissues  
except  central  nervous   system.
5 
.   Thus  Clindamycin  has  become  one  
of  the attractive  options   to  treat  MRSA  infections   those  acquired  in  
the  community (CA-MRSA)  as  well  as  in  the  hospital. 
6 
  
The Macrolide-Lincosamide Streptogramin  B (MLSB)  antibiotics  
which  was  used  for  treating  Staphylococcal infections  also  resulted  in  
resistant  strains. 
7
  Since  1968   Clindamycin  resistance  induced  by  
Macrolides   was  noted  among  the    Staphylococci  that  resulted  in  
treatment  failure  with Clindamycin . The  development  of    resistant  
mutants  resulted  in    failure  in  the   treatment   with  Clindamycin .This  
kind  of  resistance  could  not  be  tested  by  the  routein disc  diffusion  
method but  can  be  detected  by D-test.  
Two different resistant mechanisms  occur  in  Macrolides –
Lincosamide Streptogramin B (MLSB) antibiotic   resistance .The. msrA  
gene codes   efflux mechanism which  is  responsible  for  the MS   
phenotype .The  resistance  to  Erythromycin  and  either inducible  or  
4 
constitutive  resistance  to  Clindamycin  which  is  due  to methylation  of  
23 S  rRNA   is  coded  by  erm  gene.   
There  are  numerous reports  of  inducible  resistance  to  
Clindamycin  (iMLSb).  This  kind  of resistance  cannot  be  detected   by  
routine  testing  methods.  When   Clindamycin   susceptible  Staphylococci  
that  are  resistant  to   Erythromycin   are isolated,  the   D-zone  test  for  
inducible resistance  to Clindamycin    has  to   be   performed . 
7
 It   is  
mandatory  to  check  for  inducible   resistance before  declaring   
Clindamycin   sensitivity   .  A negative  D-test  confirms  the   Clindamycin 
sensitivity  .This  test  helps  us   to  use   Clindamycin    to   treat   
infections  produced  by  Staphylococcus.
4 
 
The erythromycin ribosomal methylase (erm) genes responsible for 
Staphylococcal  strains  show  cross resistance to MLS antibiotics .There  
are three  methylase  genes  in Staphylococci, namely ermA, ermB and ermC 
The expression of ermA is  inducible by erythromycin, but ermB and  ermC 
may be either inducible or constitutive.
8
 
In  this   present study the antimicrobial susceptibility patterns for 
Erythromycin, Clindamycin  and Cefoxitin was  evaluated by D test and 
Cefoxitn disc diffusion  test .The  erm  gene responsible  for  inducible 
Clindamycin resistance was  detected by  PCR . It   is  essential  to  know  
the   accurate antibiotic susceptibility pattern of  any pathogen   for  making  
5 
appropriate therapeutic decision. .Hence it  is  necessary  to identify the 
mechanisms that confer    resistance  to MLS    antibiotics  with  regard  to 
Clindamycin for Staphylococcal infections. 
It   is easy to perform the ‗D‘Test along   with  routine    susceptibility  
testing  . This  helps  us  to know  about  the local data regarding inducible     
resistance  to clindamycin  and  guides  in  treatment of Staphylococcal 
infections ,thereby  avoiding therapeutic failures.
9
 
Thus  the  purpose  of  this  study  was  to  detect  the incidence  of  
inducible  resistance to Clindamycin    among    Staphylococcal  strains  
from  clinical  samples  of  our  geographical  area.    
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2. AIMS AND OBJECTIVES 
 
 To know the antibiotic susceptibility pattern of isolated 
Staphylococcal strains  from  clinical  samples. 
 To known  the Methicillin   susceptibility  pattern  among   clinical 
samples of   Staphylococcus aureus  and  CONS  by    Cefoxitin  disc 
diffusion   test. 
 To know the incidence of inducible resistance to Clindamycin  among 
Methicillin  resistant Staphylococci and Methicillin  sensitive 
Staphylococcal  isolates by Double disk approximation test  in  both  
Staphylococcus  aureus  and  CONS isolates. 
 To detect  erm  gene in inducible  Clindamycin   resistant 
Staphylococcal  isolates  by  Real Time  PCR. 
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3. REVIEW   OF LITERATURE 
                             
The  name  Staphylococcus   was first  named by   Ogston (1883)  for    
cocci occurring  in  groups   which caused infection  and  prqduction  of  pus 
in    soft  tissues.  He  also  differentiated  pathogenic  cocci   into  one   in  
groups   called  ―Staphylococcus‖  and  the  other which  appeared  in   
chains   named  ―Streptococcus.‖   
The genus Staphylococcus   produced  a   group    of    species  which  
were   wide different   from   Micrococcus.  Staphylococcus   had   only    
three   species  until  1970 . 
10
     To  date,  there  are  32  species  and  eight  
sub-species   most  of  which  preferentially  colonise   the  human body.     
 
3.1   STAPHYLOCOCCAL   SPECIES: 
Staphylococci   are  Gram positive   bacteria    which   divides  in    
planes  to  form  grape-like clusters.  There  are    two    important  species . 
Due  to  the  rise  in  antibiotic  resistance   Staphylococcus aureus    has  
become  a   major   pathogen  of  increasing  importance  
3.2  GENERAL  CHARACTERS:                                
Staphylococci  are   non-spore  forming ,non  motile anaerobes,   
which  grow  by  aerobic ,anaerobic methods  of  respiration. Most strains   
have  a  relative  complex  nutritional  requirement, so  that  they  require  an  
8 
organic  source  of  nitrogen,   supplied  by  essential amino acids, e.g. 
arginine,  valine. Members of Staphylococci  genus  are  catalase-positive  
and  oxidase-negative,  and   are  tolerant  to high concentration  of  salt.
11
 
3.3  STAPHYLOCOCCUS  AUREUS:                                                          
Despite  their  phylogenic  similarities   Staphylococcus aureus  is  
distinct  from  the  CoNS   (e.g. Staphylococcus epidermidis)  and  more  
virulent.    The   named  aureus,  refers  to  the  colonies  that  are golden  
colour  when  grown  in  solid media,  while  CoNS  form  pale ,translucent  
and  white colonies.  Pathogenic   Staphylococci  clot  blood  due to 
coagulase production  .
11 
3.4 STAPHYLOCOCCUS  EPIDERMIDIS: 
Staphylococcus epidermidis  are gram-positive cocci  nonmotile and  
coagulase  negative that  are  most commonly  found  in  the  human skin. It 
is non-pathogenic in healthy people but there  is  risk for developing an 
infection  in  people with compromised immunity.
29 
 .Various strains of 
Staphylococcus epidermidis  form  biofilms   which   impairs  wound  
healing.  
12
                                                                                                                                                                                                          
3.5    HABITAT: 
Staphylococci  are   the  major  bacteria  inhabiting the  skin,and 
mucous membranes. The  important  areas of  colonization  of  
Staphylococci in  the  human body  are  the  face,  axilla  and groin. The   
9 
axilla  contains  high  humidity,  higher  pH than the  general skin surface 
and with rich  eccrine and  apocrine  glands  that augment the growth of  
Staphylococci.  
The    nose   provides   the  dominant  ecological  site  for  
Staphylococcus   aureus  and   a  major  habitat   for  Staphylococcus  
epidermidis. The  populations of  Staphylococci  reach  very  high   densities 
in these  habitat (c. 104–106 cfu/cm2). Staphylococcus epidermidis and  
Staphylococcus hominis  are the major species  of  the  axillae  and  groins 
13
  
Staphylococcus aureus is a member of commensal microflora and 
readily colonises the anterior nares. Nasal carriage acts as an endogenous 
reservoir for clinical infections in the colonised individuals or as a source of 
cross-colonisation for community  spread.
11
 
3.6  CARRIER:   
Staphylococcus aureus  is  localized to the  nares  by   attaching   to  a  
region of moist  epithelium  devoid  of  cilia  as  its  adherence  is  poor  to  
ciliated  epithelium. The  elimination of  nasal  carriage  by  topical  
antibiotics leads to loss of carriage in  both  axilla  and  perineum which 
appears  to  be  a  temporary  resident.   
There are three Staphylococcus aureus  carriage   patterns  described  
in  adult population, with  20  %- being persistent Staphylococcus aureus 
carriers, 60%-intermittent carriers, and 20 %- persistent non-carriers. 
10 
Staphylococcus aureus   carriage   are  found   to   be   higher  in  those  
individuals   who   are   infected   with   human immunodeficiency  virus , 
insulin-dependent diabetes,  in  intravenous  drug  abusers,  in  hemodialysis 
patients  and   patients with continuous   ambulatory peritoneal dialysis . 
13
 
3.7  MORPHOLOGY: 
The   genome of  Staphylococcus  aureus  is 2.8Mb in  size  and  its   
cell  wall  of   is  about  20 nm   .It  is the  outer  coat present and   beneath  
this   is the cytoplasmic  membrane  that  covers  the  cytoplasm.
11
 
3.8   CELL  WALL : 
Peptidoglycan is the basic component that makes up   the  major  
portion  of  the  cell  wall   . It  helps   in  the  development  of the compact 
several layers  that withstands   the high internal osmotic pressure of 
Staphylococci . The next major  component  are  the  teichoic  acids  
contributes  to   about  one third  of cell  wall. 
Peptidoglycan together  with  teichoic acid thus forms the   major 
portion   of the mass  of  cell wall  and  the rest is contributed  by  surface 
proteins,  peptidoglycan  hydrolases   and  exoproteins .   Two major types  
of  teichoic  acids are  present . They  are  that  present  in the  cell wall   and  
other  one  associated with  cell membrane. They are  composed of N-
acetylamino sugar  and sometimes D-alanine 
11
. 
 
11 
Most Staphylococcal species posses  teicholic  acids  which are   
found  sometimes  slightly   exposed to the exterior and  this  forms region  
for  the  attachment  of   antibodies and bacteriophages 
13 
Teichoic acids 
produce a negative charge to the Staphylococcal cell surface  and play an 
important  role in the  localization of metal ions and the activities of 
autolytic enzymes . 
11 
Some of the cell  surface components act  as virulence determinants 
and  are  involved in attaching the bacteria to surfaces . About 90% clinical 
strains of Staphylococcus aureus possess capsular polysaccharides . Capsule 
production decreases phagocytosis  in vitro, and   enhances virulence  of 
Staphylococcus aureus   in a mouse bacteraemia   model  therefore acts as a 
form of biofilm.
64
 
3.9 BIOFILM: 
Biofilm is a mode of survival during unfavorable conditions for 
various microbes. The bacterial cells  form aggregates in this mode of living 
thus  become  resistant to antimicrobial agents, harsh environmental 
conditions  and  to  immune cells. They form channels which serve to 
diffuse waste products  away  and nutrients into the biofilm .
12 
The two steps in   formation  of  biofilms  in Staphylococcus 
epidermidis are first, bacteria adhere to a surface by teichoic acids, surface 
material unspecific factors such as hydrophobicity, and several proteins. 
12 
This is followed  by  the  actual accumulation of biofilm .  Biofilm 
associated protein (bap), accumulation associated protein (aap)   autolysin E 
(altE), and  intercellular adhesion (ica). are the  major genes involved  
biofilm formation . 
3.10 STAPHYLOCOCCAL   INFECTIONS 
Staphylococci  causes  skin  infection  which  may  be  localised  
folliculitis,  deeper  furuncles  and  still  deeper  infections  like  carbuncles  
and  impetigo. Bacteremia  leads  to  spread  of  infection  to  internal  
organs
. 1
 Burns patients  are  more  susceptible to  staphylococcal  
infection
14
. The  major concern for people with catheters, heart valves or 
other implants  is that various  strains of Staphylococcus epidermidis  that 
forms biofilms on various metals surgical  implants  and materials other 
than surgical implants.
12 
3. 11  METHICILLIN  SENSITIVE  AND  RESISTANT  STRAINS: 
In humans, both MRSA and MSSA strains of  Staphylococci  are found 
as normal commensals on the skin mainly the arm  pits and the  nose  . Most 
hospital associated MRSA develop in people who harbor the organism in 
the nares, but community-associated MRSA  occurs  in those  who  have  
colonizing  sites other than the nares. Clinical cases occur in patients who 
are not colonized.   
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Colonization with Staphylococcal aureus occurs after birth  at  any 
time and carriage may be transient or may  be  persistent. MRSA are 
transmitted, often via the hands by direct contact of colonized or infected 
people.  The carrier state persists as long as person is infectious or when  the  
lesions remain active. MRSA can   be transmitted  through  fomites , food  
contaminated by  carriers and in aerosols. They can also be transmitted 
during delivery from the mother to her baby. 
12.
 
There  is  an  increasing  incidence  of  MRSA  among  the  normal 
persons  and  those  hospitalized .This  increasing  trend   has  led to   
increase in  the  invasive infections .
15
  The resistance to antimicrobial 
agents among  nosocomial   pathogens is an increasingly global problem 
worldwide. 
16
  
The   genetic  material   present  on  the   movable   portion    of  
Staphylococcal   chromosome which  is the   mecA gene   is  responsible  for  
the production  of   resistance to  Penicillin  group  of  antimicrobials.
17 
        Household  Methicillin  resistant  strains  are  maintained  due  to  the  
colonization of pets which is often transient.
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 Clustered outbreaks of  
community-associated MRSA infection are  isolated within prisons, and 
among athletes  who  share equipment in Native American communities. 
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The  sensitivity   of   Trimethoprim - sulphamethoxazole and 
Tetracycline, among  the Vancomycin  intermediate  and  resistant  strains  
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of   Staphylococcal  isolates led to  the   rise in the   efficiency  of  older 
antimicrobials  which  can  be  used  to  treat   infections due to MRSA.
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3.12.MACROLIDE  LINCOSAMIDE AND  STREPTOGRAMIN B 
The re is  a increased   rise in  the  resistance to antimicrobials  among 
microorganism  that   necessitates  the need  to know the susceptibility of 
the  organism  towards  antimicrobials and  to  select  the  appropriate   
antibiotics   for the  treatment  of  infection.
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This  has  led  to  an  interest to  use of  Macrolide  Lincosamide–
Streptogramin B  (MLSB) antibiotics in  the  treatment  of  Methicillin  
resistant  Staphylococcus   aureus (MRSA) infections .
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Antibiotic collectively named MLSB  are a  group  of  Macrolides   
(e.g.  Erythromycin,  Azithromycin,   Spiramycin)   Lincosamides 
(e.g.Clindamycin ,Lincomycin),and Streptogramin B (e.g., Quinupristin) 
which  are different  in  their   chemical    nature, but are  found   to  have  
similar  mechanism  of  action  on inhibition effects on bacterial protein 
synthesis .
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Erythromycin (ERY) a Macrolide and  Clindamycin (CLI) a 
Lincosamide  belongs to different  classes of  antibiotics  of the MLSB 
family with  similar  mechanism of action and resistance. They  inhibit     by 
binding  to the 50s ribosomal subunit .
23
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The   tremendous use of MLSB antibiotics   led  to the emergence of   
acquiring resistance to MLSB antibiotics by increased number of 
Staphylococcal  strains. The  target site   modification  by erm genes has  
been the mechanism for such resistance . Phenotypically   this has  been  
seen    one  in  the i MLSB phenotype  the   other  found  to  be  c MLSB 
phenotype
24
 
In    the presence of    Macrolides,   but not   Lincosamides                                
the   inducible phenotype is expressed . This  results  in  failure  in  
treatment  with the use of   Clindamycin   in  iMLSB phenotype and  this  
lead to  the   selection of  cMLSB  especially  in  deep seated  infections    
leading  to  bacterial burden.
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It  is  necessary   to  assess   the frequency or prevalence of   iMLSB  
because  during  therapy these  strains have a great level  of  potential in  the  
production   of erm gene that  lead   to develop constitutive resistance to 
Clindamycin .
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The    resistance   occurs  in Staphylococcal  isolates  which are  
susceptible  to    Clindamycin  among  resistant  strains  to Erythromycin  
The expression of erm gene which  occurs as a   product  of   methylase of  
ribosome  which   is produced  in  small  amount . These strains are  usually  
produced   in     resistant  strains   to  Erythromycin   as  this  induced    the 
methylase  production  but they can also  be  produced  in  the  absence  of  
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inducer which   occurs  in   mutations  of   the promoter region of erm  
gene.
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3.13 CLINDAMYCIN:  
Clindamycin  belongs  to  the  antibiotic  group Lincosamide  . It  
inhibits   protein  synthesis   .It  is  available in  Capsules  of   strength  of   
150 mg, 300 mg . Tropical  forms   are  available  as  creams .For  vaginal 
use , Vaginal Suppository ,  foam  and  gel  are  available. Parental  
intravenous  injections  are  also available 
There  are  many   types  of      Lincosamides   that   have  been  
prepared  but  only  Clindamycin and Lincomycin   are the  antimicrobials  
used  to  treat   infections .Clindamycin   is   produced  chemically  while   
Lincosamide   is produced  from    Streptomyces   lincolnensis.
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Clindamycin  is  one  of  the  alternative  drug  used  in  Penicillin 
allergy  patients  to  treat  deeply    situated   infections. It inhibits Panton-
Valentine  Leukocidin which  is  a  toxin.
14
Clindamycin    can  be  used  in  
Staphylococcal  isolates  resistance  to  Methicillin. Furthermore  it  gets  
deposited   in  deeply   situated abscesses and  same  dose  can be  used  in  
kidney  infections.. This  drug  has  excellent   oral absorption    making   it  
as   an great   option for follow-up  treatment   after   parental  route  of  
administration  during   hospitalisation
29
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The  following  reasons   makes  Clindamycin as  a  drug  of  choice.It    
is available in  oral as  well as  parental   formulations. , the drug    is 
remarkably  present  in  skin   and  finally  it  is  used  in  MRSA  infections  
which  are  rapidly emerged in recent years , is frequently susceptible  to  
Clindamycin  .
30 
 So   this   has  been  a  better    option  for  the  treatment  
of   these  resistant  strains   causing  infections. 
31
  
 Staphylococcus aureus isolates   with   Clindamycin resistance  is 
mostly    accompanied by Macrolide   resistance. This  is  due  to   the erm 
genes, which  mediates   Clindamycin resistance  that  occurs  due  to  the   
modified   site which  is shared by Macrolides, Lincosamides and group B 
Streptogramin (MLSB) antibiotic  groups.
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The   cause  for  the unsuccessful therapy with lincosamide in 
erythromycin-resistant  strains with the msr(A) gene is that   the therapeutic   
effect of   lincosamides   is maintained  which   favors   the switch from the   
inducible to the constitutive   type of erm expression . 
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3.14 MACROLIDES:    
Macrolides  are  group  of  bacteriostatic   antibiotics  that  act   by  
binding  reversibly  to  50S  ribosomal  subunits   of  the  susceptible 
organism. The  mechanism  of  acquired  resistance  to  
Macrolides,Lincosamide  and  Streptogramin B (MLSB) antibiotics  in  
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Staphylococcus  aureus  is  due  to  the  target  site  modification.This  
confers  cross-resistance  to  the  MLS  antibiotics. 
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The  pathogenic Staphylococcus aureus,  and  the    potentially  
pathogenic  Coagulase-Negative Staphylococci  (CoNS) are   carriers   of 
genes for resistance to macrolides
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Nowadays    resistance  to  Macrolides   is increasing worldwide. 
Inducible resistance has  been found to be more than 50% in MSSA and   
constitutive phenotype resistance more than 80%  in MRSA . It  has  been  
10.8% in MSSA and  82% in MRSA in Sout Africa
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3.15 STREPTOGRAMIN  - B 
The treatment  of infections caused by multidrug resistant and Gram-
positive pathogens  can  be  done  using  Quinupristin Dalfopristin 
(Synercid,30:70 ratio)  which   is the first parenteral  Streptogramin   
licensed for clinical use  in the United States and Europe .Quinupristin and 
Dalfopristin enter bacterial  cells  by diffusion .It  results  in an  irreversible  
inhibition of  bacterial protein  synthesis   by  binding   to different sites on  
the 50S  ribosomal subunit, 
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3.16 MECHANISM   OF   RESISTANCE  TO  MLSB  ANTIBIOTICS: 
Lincosamides   and    Macrolides    binds   to   the   same or closely 
related binding sites  in  the bacterial ribosome .Resistance  to Macrolide, 
Lincosamide, and Streptogramin B antibiotics  (MLS phenotype)  occurs   
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through  methylase  enzyme that  alters  the   antimicrobial  drug binding  
site   by   removing    the  methyl group from an adenine residue in  the 23S 
rRNA component of the 50S subunit of the ribosome .This  alters  the  
efficacy  of  the  drug   .
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 The most effective inducer of  inducible MLSB 
resistance is  the low levels of Erythromycin 
37
 
The Macrolide- Lincosamide –StreptograminB (MLSB) family of  
antibiotics   which  are structurally unrelated  but  serves as  drug  of  choice  
in  resistant Gram positive organisms, including  both  staphylococci and 
streptococci The MLS  antibiotics  are related microbiologically  by   their 
similar modes of action  as they   inhibit protein  synthesis by binding to the 
23S r RNA.  
Clindamycin  has  excellent tissue penetration except in CNS because 
it accumulates  in abscesses.It has good oral absorption and no dosage  
requirement  in  renal diseases .Thus   is the preferred agent in this group . 
In penicillin allergic patient  it   is also a useful alternative for penicillin 
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.    
Acquiring resistance to MLSB antibiotics occurred  due  to  the   
widespread use of MLSB antibiotics  in Staphylococcal  strains
39
 . This   
acquired  resistance can be either constitutive  where methylase is always 
produced  or inducible type.
40
  
The modification of the ribosomal target is encoded by erythromycin 
ribosome methylase (erm) gene which  is a  multiallele plasmid borne and  
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leads  to   the production of the methylase enzymes. The A2058 residue  
located  in the conserved domain V of the 23S rRNA  which  is a 
component of the 50S ribosomal subunit, is  methylated  by  the  methylase  
enzyme .This   lead  to cross resistance and the formation of the phenotype 
of the resistance pattern, called as the MLSB – resistant phenotype41. 
Methylase is always produced   in case of constitutive resistance, 
whereas in inducible resistance , methylase  is  produced   only  in  presence 
of   inducer like Erythromycin   
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Macrolide resistance may  be  conferred  by  efflux mechanism 
encoded by msr(A) (MS-phenotype ) or  as  ribosomal target modification 
that affects activities of Macrolides ,type B Streptogramins and  
Clindamycin (MLSB-resistance) 
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In   Staphy-lococcus  species  Clindamycin resistance can be either 
constitutive or inducible. The  target site modification mediated  by  the  
erm  genes,is  expressed either constitutively(constitutive MLSB phenotype) 
or inducibly  (inducible MLSB phenotype). It  is  difficult to detect in the 
routine laboratory the  strains with  Inducible  resistance to Clindamycin 
44
  
In the presence  of  low levels of inducers, such as Erythromycin  the 
expression of the MLSB  phenotype can be either constitutive or inducible . 
The  erm genes are  encoding   enzymes that confer inducible or constitutive  
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resistance. There are  three  expression of MLSB phenotypes  which can be  
described as constitutive (MLS Bc), inducible (MLS Bi) or MS phenotype
33 
 
                              
In   MSB resistance   due  to  the  expression   of  mrs (A) gene . does  
not  produce   resistance  in   clindamycin   which   remains active . In  this  
resistance  an active efflux occurs , due to energy-dependent pump,. The  
modifi cation of the drug-binding site on the bacterial  ribosome, encoded 
by erm genes (erm (A) or erm (C) in staphylococci results in resistance to 
Macrolides,Lincosamides and type B  Streptogramin (MLSB resistance
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When not placed adjacent to each other they appear  as  Erythromycin 
resistant and Clindamycin   sensitive in vitro but  they  show  therapeutic   
failure  in-vivo therapy with  Clindamycin 
45
 
Constitutive resistance can  be easily  but  it  is  difficult  to  detect   
inducible resistance is by routine antimicrobial susceptibility tests.  In  order  
to  detect  inducible  clindamycin resistance (ICR) in isolates of 
staphylococci,according to the recommendation of the Clinical and  
Laboratory Standards Institute (CLSI), it  is  necessary   to  subject  to the 
D-zone test.
46
 
3.17.D-zone test:  
A  lawn  culture  adjusted to 0.5Mcfarland‘s concentration   of  the  
isolate   was made on a Mueller Hinton agar plate.  Along with routine 
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antibiotic susceptibility  testing   the   discs of  Clindamycin (CL (2μg) and   
Erythromycin  ER (15μg) were placed at a distance of  15mm (edge to edge) 
as per the CLSI recommendations. Based on the D test, the  disc diffusion 
test  showed four phenotypes. 
The Inducible MLSB phenotype (iMLSB):  D shape  in  the  Clindamycin  
zone  is  known  as   inducible resistance to clindamycin  . 
The Constitutive MLSB phenotype (cMLSB): strains  appearing  resistant  
to  both  drugs.  
The MS phenotype: strains  of  erythromycin   resistantce   and  
Clindamycin     susceptible . 
There  is  a  zone of flattening   near   to the erythromycin disk ( D – test 
positive.) indicate  iMLSB . sometimeswithin the zone of inhibition around 
clindamycin   growth   may  occur  indicates  resistance to  Clindamycin. 
3.18 INTERPRETATION  OF  D-TEST: 
When  an isolate demonstrates inducible clindamycin resistance   D- 
shaped zone   is  seen    around the clindamycin disk  .Clindamycin is 
reported as  resistant   in  the  report  .There  is highly predictive of the 
organism   producing  a positive D-test result  in  cases of  diabetes, cystic 
fibrosis, immunodeficiency  and     postsurgical status. The relative 
frequency of inducible resistance  is   tested   periodically  which  helps   in 
tailoring empiric  therapy for suspected S aureus infections
63
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D-test  helps  in  the  phenotypic  determination   which is confermed  
by PCR  to detect erm A,ermB,ermC genes in  clinical Staphylococcal 
isolates from the USA
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    ermA and ermC were found  to  be  responsible   
for the iMLS  and   MS-phenotype  showed  strains that are  not  capable  to  
hybridize with   the probes of  erm  gene .
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The  erm  genes   erm(F)], erm(A) and erm(C) are  responsible  for 
the iMLSB resistance in staphylococci, which occurs  as  either  cMLSB  or 
inducible
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The    classes of the erm genes erm(A), erm(B), erm(C) are 
responsible  for for     iMLSB . Erythromycin induce   methylase   that   
produce Clindamycin   to express  its  resistance.
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In   MS resistance  the   mechanism, is that   Streptogramin B  14- and 
15-membered  Macrolides to  which   partial cross-resistance occurs   and 
which is conferred by  gene msrA  .This   is  due  to  the active efflux of 
antibiotics
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There  is  variation  in  the the amount  of Staphylococci  showing   in 
vitro iMLSB    among  hospitals  graphic region, age group, bacterial 
species and Methicillinsusceptibility
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The developing patterns of drug resistance  should  be  kept  a close 
watch  by  the clinical microbiologists and infectious diseases experts which  
helps  them  to guide therapy effectively. 
60
 
24 
As   Clindamycin resistance  vary by methicillin  susceptibility   and   
geographic region and  the high frequency of MRSA isolates with in vitro  
resistance   to  Clindamycin  necessitates  the  determination  of  inducible   
Clindamycin  resistnce  in  individual settings. This  is  of  main concern  as  
treatment  failures  with  Clindamycin  may  occur with these  Methicillin  
sensitive  and  resistant  strains. 
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Inappropriate  therapy of  Staphylococcus aureus  which  were   
reported  as susceptible to Clindamycin without performing    D-test . While  
a  negative D-test  result will confirms susceptibility  for   Clindamycin  and 
helps  to  provide   a  good  option for  treatment.
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Prevalence of the two phenotypes  necessitate   us  to test each  isolate  
of  Staphylococcus  for    inducible  Clindamycin resistance.  If MS 
resistance is uncommon, in the  locality  ,most  of  the  labs  will not do 
 D-test but they  report  as Clindamycin resistant  for  every  Erythromycin 
resistant  isolates  .
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Multidrug resistant. Methicillin resistant strains (MRSA) remain in   
high priority for hospital  epidemiologist, since these strains are virulent  
much more difficult and  expensive to treat as  they  are  virulent .
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The major problems faced while controlling MRSA in the tertiary  
care hospital  are  the  environment .persistence of MRSA carriage  
increasing  number of patients at risk of acquisition ,inadequate   isolation   
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facilities for  isolation  of  the  organism ,problems in identifying the source 
of outbreak, inadequate  antibiotic and admission policy .
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There  is  a   high risk of colonization  of   Methicillin resistant 
Staphylococci  in  HIV- infected patients  Increasing  use of  Clindamycin,  
among  MRSA   clones  will complicate    the treatment  of  these  infections  
present   in the community  
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Resently   there  are  many   automated or  semi-automated  machines  
to  detect  antibiotic susceptibility testing (AST) . The BDXpert System, the 
BD Phoenix™ A and BD EpiCenter™ System are  some  of  the  automated  
AST  systems  which  help  us to  provide    test  results as per  CLSI  
guidelines.
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 Vitek (bioMerieux) – V1, and MicroScan MICroSTREP 
Plus(Dade Behring) – MS  are  few   automated  systems  used   for  the  
interpretation   of  AST  results.
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4. MATERIALS AND METHODS 
 
This  study  was  conducted  during  the period  from  April  2013  to  
May  2014   at  the  Department  of Microbiology,  Tirunelveli  Medical  
College , Tirunelveli. 
4.1 INCLUSION  CRITERIAS: 
During  the  study  period   a  total  of  100  non  duplicate  clinical  
isolates   of  Staphylococci  were  collected  from   different  clinical  
samples  like    aural  swabs,  wound  swabs  ,pus and  vaginal  swabs  from  
both  in-patient   and  out-patient  departments  of  Tirunelveli  Medical  
College  .  The  Staphylococcal  species  were  identified  by  standard   
biochemical   techniques. 
4.2 EXCLUSION CRITERIAS: 
  Patients   who  were  already  on  treatment  with  clindamycin . 
 Samples  from  patients  producing  positive  culture  but  with  no  
signs  of  infection . 
A  detailed  history  regarding  previous  hospital  admission  within  
two years,  antibiotic  intake  in  previous  six  months  was  elicited  from 
every  patient. 
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4.3 Ethical clearance:  
As  this  study  involved  the  clinical  samples  from  the  patients, 
ethical  clearance  was  obtained  before  the  commencement  of  the study. 
4.4  Informed consent:   
Informed   consent    obtained  from  all  persons  involved  in  this 
study. 
4.5  Proforma: 
A  filled   in  proforma  was  obtained  from  the  patients  with details  
like   name,  age,  sex,  ward,  clinical  diagnosis,  risk  factors, surgical   
intervention,  hospital  stay, previous  use  of  Clindamycin  or on  any  
other  antibiotics   and  other  parameters  relevant  to the  study. 
 4.6  Sample storage: 
The  Staphylococcal  isolates  were  sub-cultured  on  to  nutrient agar  
slope  and  stored  at  2 to 8˚C.  The   Staphylococcal  isolates  were  sub-
cultured every  fortnight. 
4.7 Primary isolation and identification of Staphylococci  :  
4.7.1  Samples:  
During  the  study  period pus collected  from abscess, wound  swabs 
from  discharges  in  skin  infections, ear swabs  and  vaginal  swabs were  
collected  from  those patients attending outpatient& inpatient department  
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in Tirunelveli  Medical  College  .  Samples   which  were received  was  
processed  within  two  hours  of  receipt  as  per  standard procedures. 
 4.7.2   Microscopy:  
Gram  positive  stained  cells   appearing   spherical  on  light 
microscopy . These  cocci  appear  in clusters as  division  occurs  in  two  
are more  planes    Staphylococcus aureus  mainly  produced irregular  
clusters  of  cells and Coagulase  Negative Staphylococcus  mainly 
produced  aggregates  of  tetrads  and  pairs. 
4.7.3   MORPHOLOGY: 
Staphylococci  produced  classical  colonies  on  a  variety  of 
commercial  agar  media. In  gram stain samples  showing  Gram  positive  
cocci  in  clusters ,tetrads and pairs  were  processed .  Samples  were  
streaked  into  both nutrient and  blood  agar, incubated  at  37
0
c  for  18 to 
24  hours. Presence  of  large  (2-4mm diameter), circular,  smooth,  golden  
yellow  or  cream  coloured,  opaque,  easily  emulsifiable  colonies  on  
nutrient  agar  were  noted.  On blood agar  β-hemolytic  colonies and no 
hemolysis on  some plates were  observed  with  similar morphology. 
Mannitol salt agar was  used as selective media  . Pigment  present on 
colonies were of different shades  depending on the particular species and 
strain. 
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4.7.4 Biochemical reactions:  
Catalase test:  
                        It was done by slide test or tube test. 
 Slide   test- 
A  single  colony  taken  from  nutrient agar  plate  was  placed  over 
the  clean  glass slide,  to  this  one  drop of  3%  H2O2(hydrogen peroxide) 
was  added,  effervescence  was  observed. When  effervescence  appeared  
it  was  a  positive  test. 
 Tube test-  
1ml  of  3%  H2O2  was  taken  in  a  small  test  tube,  small amount  
of  bacterial  growth  was  introduced  with  the  help  of  glass rod  or  
plastic  applicator  stick , effervescence  was  observed.  
 Control  :   Positive   and  negative  strains  were  tested  simultaneously .  
COAGULASE   TEST: 
Tube coagulase test detects  Free  coagulase  and  slide coagulase test 
detects bound  coagulase . Slide coagulase  test  was    used  to  screen  
strains of  Staphylococcus aureus  and  tube coagulase  was  used  to  
confirm it. 
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SLIDE COAGULASE TEST: 
Principle: 
Other name for bound coagulase is clumping factor. fibrin clot that 
deposits on the cell wall is formed by cross-links of α and β chain of 
fibrinogen in plasma.So individual  cocci  stick to each other and form 
clumps. 
Procedure: 
Staphylococci   dense  suspensions  from culture was made on both 
ends of a glass slide and  labeled as ―test‖ and ―control‖. The control  serves 
to rule out false positivity due to autoagglutination. The test sample was 
treated with a drop of citrated plasma .Clumping of cocci in 5-10 seconds 
was  considered as positive. Some strains   did  not produce bound 
coagulase, and  were  identified by tube coagulase test. 
TUBE COAGULASE TEST 
Principle:  
The free coagulase of Staphyloccus aureus reacts with coagulase 
reacting factor (CRF) in plasma to produce a complex, (ie) thrombin. This 
thrombin converts fibrinogen to fibrin clotting of plasma occurs. 
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Procedure: 
   Three test tubes  labeled as ―test‖, ―negative control‖ and ―positive 
control‖ were  taken and filled with 0.5 ml of 1 in 10 diluted rabbit plasma. 
0.1 ml of overnight broth culture of test bacteria was added to the tube 
labeled test.andt to the tube labeled positive control, 0.1 ml of overnight 
broth culture of  known Staphyloccus aureus  was added and  to the tube 
labeled, negative control 0.1 ml of sterile broth was added. The tubes were 
incubated at 37
o
C for four hours. Gelling of the plasma, indicates positive 
result. The test which  were  negative, were  kept at room temperature for 
overnight incubation and  observed  the  next  day. 
4.8  Antibiogram: 
All identified Staphylococcal  strains were  then tested for Antibiotic 
susceptibility on Mueller-Hinton  agar  plates by the Kirby-Bauer disc 
diffusion method. Antibiotic   discs    used  are  Ampicillin (10 μg), 
Amoxyclavulanic acid (20/10 μg),  Ciprofloxacin (5 μg),) Doxycycline (30 
μg), Erythromycin (15μg), Gentamycin (30 μg), Cefoxitin (30μg)  
Clindamycin (2 μg), Co-trimoxazole(23-75/1-25mg) and Vancomycin 
(30μg).  
Control:    Staphylococcus ATCC 25923  used as the control strain . 
Methicillin  resistance was detected by using Cefoxitin  disc. 
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4.9   D-test: 
4.9.1 PRINCIPLE: 
Macrolides resistance can occur by two different mechanisms:  
 1) Efflux due to Macrolide Streptogramin resistance (msrA gene) 
  2) Ribosomal  alteration due to erythromycin ribosome methylase  
(erm  gene ). 
 MLSB -resistant   phenotype  is  the  most  frequent  mechanism   of 
resistance. Genes encoding  these  methylases  have been designated  erm 
(erythromycin ribosome methylation). Expression of resistance to  MLSB  
in staphylococci are either constitutive (MLSBc) or inducible (MLSBi). If it 
is is constitutive, the strains are resistant to all MLSB  antibiotics and if it is  
inducible, the strains are resistant to 14- and 15-membered macrolides.  
 In  MLSBi strains, Macrolides will produce methylase, which allow 
Clindamycin resistance to develop and this   resistance  was identified with 
the D test   
4.9.2  D –Test PROCEDURE: 
The Erythromycin resistant isolates were subjected to D zone test for 
inducible Clindamycin resistance as per the CLSI guidelines.  All antibiotic 
discs were procured from Himedia India, Private Ltd  
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D-zone test: - on a Mueller Hinton agar plate a lawn culture of the 
isolate which was adjusted to 0.5 Mcfarland‘s concentration was made and 
discs of Clindamycin(2µg),Erythromycin(15µg) were kept at a distance of 
15mm. 
The disc diffusion D test, showed   
 Inducible MLSB phenotype (iMLSB ) 
  Constitutive MLSB phenotype (cMLSB) 
 MS phenotype 
The Inducible MLSB phenotype (iMLSB): 
Clindamycin Inducible resistance was manifested by  blunting of  the  
Clindamycin  zone neart  the Erythromycin  disc, giving a D shape.  
The Constitutive MLSB phenotype (cMLSB): 
Isolates which were resistant to both.  
The MS phenotype:  
Strains which were resistant to Erythromycin but susceptible to 
Clindamycin. 
4.10  Real-Time PCR : 
The  Staphylococcal  isolates  from  MLSBi  were  further  tested 
gene  by  Real-Time  PCR from  Helini  Biomolecules  for  
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ermA/ermB/ermC  genes. and  procedure  followed according  to  the  
manufacturer‘s  instructions. 
 4.10.1 Safety precautions:  
A   Biosafety  cabinet  Level-2  was  used  to  perform  all  procedures   
with  due  precautions  by  wearing  a  suitable  lab  coat,  disposable  
gloves,  and  protective  goggles. The  assay  wastes  were  discarded  as  per  
our  local  safety  regulations. 
4.10.2 Material  Required: 
 Vortex mixer. 
 Water bath. 
 Centrifuge with rotor for   1.5ml  reaction  tubes. 
 1.5ml/2ml centrifuge tubes. 
 Disposable   powder-free  gloves. 
 Micro pipettes and   tips. 
 0.2 ml PCR  tubes/8  well  strips  /96  well  plate  according  to  real   
time  PCR  machine  and  model. 
 Thermo cycler (Biorad CFX 96) 
 Computer for data storage 
 70% Ethanol 
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 Isoproponal 
4.10.3   DNA extraction: 
Each silica based spin column recovered up to 20µg of DNA and 
yielded purified DNA of more than 30 kb in size. Isolated DNA was used 
directly for PCR reaction. 
 4.10.4  Components of extraction: 
 Phosphate buffered saline 
 Lysozyme 
 Digestion buffer 
 Binding buffer 
  Proteinase K 
 Internal control template 
 Isopropanol 
 70% ethanol 
 Elution buffer 
4.10.5  Storage and stability: 
 The  kit  was  stored  at  25˚C. 
 Proteinase K  and  Lysozyme  was  stored  at  -20˚C. 
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4.10.6   Sample preparation:  
Four  to  five  colonies  of  Staphylococcal  isolates  of  MLSBi  
grown  on  NAP  slope  was  inoculated  into  one  ml  of  PBS  in  a  1.5ml  
sterile  microcentrifuge  tube.  The  tube  was  then  centrifuged  for five  
minutes  at  6000  rpm  at  room  temrerature. The  supernatant  was 
discarded  thoroughly  and  the  bacterial  pellet  was  ready  to  use  for  
DNA  purification. 
4.10.7   Principle of extraction: 
The Cells  are  lysed  by  Proteinase  K  which  immediately  
inactivates  all  nucleases .Cellular  nucleic  acids  can  bind    glass fibres  
in  the  Pure Fast   spin  column. This   bound  nucleic  acid is further   
purified  by   rapid  ―wash  and  spin‖  steps  which    removes   all   
contaminations .  Finally  with   the  help  of  elution  buffer   the  nucleic  
acids are  eluded   from  the   fibre  spin  column  . The  above  step   
eliminates  the  use  of   organic  solvent  extractions  and  DNA  
precipitation,   of  many  samples  simultaneously. 
4.10.8   Extraction procedure:                                                    
 All   the  steps  were performed  at  room  temperature. 
 The  bacterial pellet  was  mixed   in  200µl  of    buffered saline  and  
vortexed    30  seconds  to  dislodge  the  pellet. 
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 180µl  of  Digestive  buffer  and  20µl  of  Lysozyme  was  added  and  
gently  vortexed  for  10  seconds. It  was  incubated  at  37
0 
C  for  15 
min.  
 Binding buffer  of  200µl , 20µl  of  Proteinase K, and  5µl  of internal 
control  template  was  added  to  the  suspension  and  pulse  vortexed. 
 This  was  mixed  immediately  by  inverting  several  times  and 
incubated  at  56°C  for  15  minutes  in  a  water  bath. 
 300µl   of  Isopropanol  was  added  and  vortexed  for  15  seconds. 
 Entire   sample  was  pipette  into  a  PureFast  spin column. 
 This  was  centrifuged  for  one  minute  at  12,000 rpm  for  1min.   The  
column    placed  back  into  the  same  collection  tube after  discarding  
the  flow  through. 
 To  the  spin  column    add   500µl   of   70% ethanol  . 
 This   was  centrifuged  for 1min  at  12,000 rpm.  
 To  the  spin  column 500µl   70%  ethanol   added  . 
 At  12,000 rpm  this  was  centrifuged  for  1min  and discard  the  flow 
through and at 13,000 rpm   centrifuged  for    two  minute  so  as  to 
remove   the  residual  ethanol. 
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   A  fresh  1.5ml  microcentrifuge tube  was  used  to  transfer  the  spin  
column 
 75µl  of   the  Elution buffer (pre-warmed to 56˚C) was  added  to  the 
centre  of  the  spin  column  membrane. Care   was  taken  not  to  touch 
the  membrane  with  pipette  tip. 
 It  was  then  incubated for  two  minutes   at  room  temperature  and 
further  centrifuged  I min. 
 Discard     the   column    and  purified  DNA   stored at -200C.       
4.10.9   PCR amplification  
Real  time  PCR ready-to-use  kit  used  to detect  erm A/B/C  gene  
bearing  bacterium  using  polymerase  chain  reaction  (PCR).It  contains  
reagents  and  enzymes  for  the  specific  amplification  of  erm A/B/C  
gene  to  directly  detect  the   amplicon  in  fluorescence  channels  cycling  
green.There  is   an  Internal  control to   amplify  and   identify  the  
inhibition. External  positive  controls  (Positive  Template ) are  supplied 
,which  can  be  used  as  both  qualitative  and  quantitative  to  determine  
the  amount  of  bacterial  load. 
4.10.10    Specificity: 
The  erm A/B/C  primer  and  probe  are  designed so  as  to   in  vitro  
quantify    erm A/B/C genes  in  bacterium. The  target  sequences  are  
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highly  conserved  .It  act  as  a  genetic  marker.  A comprehensive  
bioinformatics  analysis is  used    to   find  the  primers  and  probe  
sequences  in  this  kit that have  100% homology  with  the  reference  
sequences  .  
4.10.11   Kit   components: 
 Probe  PCR  Master  mix 
 erm A/IC  PP mix 
 erm B Mix containing  Primer Probe 
 erm C Mix of Primer Probe 
 Internal  control  template 
 Water, Nuclease Free 
 erm A/B/C Positive Template 
4.10.12   erm  A/B/C  primer & probe mix 
The erm A/B/C   primer & probe mix consists of Taq Man probe which is 
florescent labeled with FAM, forward primer and reverse primer.  
erm A primer-  
5‘- TCA GGA AAA GGA CAT TTT ACC -3‘ 
erm B Primer- -  
 5‘- GGT AAA GGG CAT TTA ACG AC -3‘ 
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erm C Primer--   
5‘-  CTTGTTGATCACGATAATTTCC -3‘ 
erm A Probe - - 
  5‘- GAG CTT TGG GTT TAC TAT TAA TGG -3‘ 
erm B Probe- -  
 5‘- CTT ACC CGC CAT ACC ACA -3‘ 
erm C Probe— 
  5‘-  CATAAGTACGGATATAATACGCA -3‘ 
4.10.13    Internal Control primer / probe Mix             
The    limited  concentrations of the internal control primer /probe 
mix  in  PCR    allows  multiplexing  with  the  target  primers. Detection of 
the  pathogen  target  gene is  not  affected  by  the   amplification  of the  
Internal  control template  .with   the  HEX  channel the  Internal  control  is  
detected    and  gives  a  CT  value  of  26±3. 
The reason for including the internal control is to make sure that PCR 
inhibitors are not present in the extracted sample DNA and the performance 
of PCR mix ingredients are good. When no amplification was observed in 
internal control, it indicates that PCR inhibitors are present in the sample 
and efficiency of the nucleic acid purification is not optimum. It helps  the 
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false negative results to be  ruled  out .5µl  of  the  internal  control  template  
is  added to  sample/lysis  buffer  complex. 
4.10.14   Positive   and  Negative  contol 
   5 µl  of  Positive  control  added  in  the  place  of  sample  DNA  
and  5µl  of  Nuclease  free water as  negative  control  used   in  the  place  
of  DNA  sample. 
4.10.15    PCR amplification kit storage 
The kit was stored at -20˚C. 
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Table.1 :  erm  detection mix for samples 
S.No Components ermA 
 
ermB 
 
 
ermC 
1. Probe PCR Master Mix 10µl 
 
10µl 
 
10µl 
2. 
ermA/Internal Control  Primer Probe 
Mix 
10µl 
 
- 
 
- 
3. ermB Primer Probe Mix - 
 
10µl 
 
- 
4. erm C Primer Probe Mix - 
 
- 
 
10µl 
5. Purified DNA sample 5µl 
 
5µl 
 
5µl 
6. Total reaction volume 25µl 
 
25µl 
 
25µl 
 
4.10.16   The   erm  reaction mix  
The ermA reaction mix for the samples consisted of probe PCR 
master mix 10µl, ermA/IC  primer probe mix 10µl,  purified DNA sample 
5µl and a total volume of 25µl.(Table.1)  
The  ermB reaction  mix for  the  sample  consisted  of  probe  PCR  
master mix  10µl, erm B Primer  Probe  Mix 10µl,  purified DNA sample 
5µl and a total volume of 25µl.(Table.1)  
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The  ermC reaction  mix for  the  sample  consisted  of  probe  PCR  
master mix  10µl, erm C Primer  Probe  Mix 10µl,  purified DNA sample 
5µl and a total volume of 25µl.(Table1.) 
For positive control mix, 5µl of positive control template was added 
instead of sample DNA and for negative control mix, 5µl of nuclease free 
water was added instead of sample DNA. (Table.1) 
Initially negative control, followed by samples and finally positive 
control was added to prevent cross contamination. After adding all the 
ingredients, they were centrifuged and placed in the thermo cycler and  the  
pcr  reaction   was  made  to  run. 
 4.10.17    Basic steps in amplification 
 Initial denaturation - First, the temperature is raised to 95˚C for five 
minutes for Taq enzyme activation. 
 Denaturation- The temperature  elevated to 95˚C for 20 seconds,  
separates template DNA strand to two complementary strands. 
 Annealing- temperature decreased to 55˚C for 20 seconds, binds  the  
primer to the DNA template complementarily. the temperature raised  
to 72˚C for 20 seconds  leads  to  extension.  DNA polymerase 
extends the primers ., two single template of DNA strands and the 
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newly synthesized complementary DNA strands combine together 
forming two new double stranded DNA copies   after extension  
 The copy of DNA may function as one template for further 
amplification. The products will be doubled in each cycle and for 40 
cycles 
 
 The final PCR products is  2n copies of template DNA.  Data 
collection was made at the end of extension and the computer 
produces the cross threshold (Ct) value by calculating the 
fluorescence emitted at the end of each cycle.  
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Table  2:  Amplification profile for erm gene 
 
ermA/B/C=FAM  Channel 
Internal  control=JOE Channel 
 Ct value   
 When Ct value was less than 38, it was considered as positive for erm 
gene. 
 The test was repeated with Ct values between 37- 40. 
 Negative result if no amplification occured.  
 
 
` 
Step Time Temp 
Taq enzyme activation 5min 95
0
 C 
 
40cycles Denaturation 20sec 95
0
 C 
Annealing/ Data collection 20sec 55
0
 C 
Extension 20sec 72
0
 C 
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4.10.18   Interpretation  of  results: 
Negative  control 
In  the  negative  control  reactions   growth  curves  which  cross  the  
threshold   line and  exhibiting  fluorescence   are  not  found. 
Control-Positive 
The Positive  control  reactions  showing   positive  results  before  40  
cycles. 
Test  sample/specimen-Positive 
A test  sample/specimen  is    presumptive  positive  when  all  
controls  met  the  needed   requirements. 
Test  sample/specimen-Negative 
A test  sample/specimen  is    presumptive negative  when  all  
controls  met  the  needed   requirements Sample  amplification  plot  should  
cross  threshold  point  before  38  cycles. (Ct value±38) 
Internal  control-Interpretation: 
When  used  according  to  protocol  CT  value  is  expected  within  
24 to31.  However  this  varies  with  extraction  efficiency,  the  quatity of  
elute  added  to  the  PCR reaction  and  the  individual  machine  settings. 
CT  values  of  31±3  are  within  the  normal  range. 
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Table 3:   Interpretation of results 
Test 
Sample 
Negative 
control 
Internal 
control 
Positive 
control 
Interpretation 
Positive Negative Positive Positive Positive 
Negative Negative Positive Positive Negative 
Negative Negative Negative Negative Repeat 
Positive Positive Positive Positive Repeat 
 
                                          
                                       
                                                 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 Fig.1 BAP Plate - Staphyloccus aureus colonies 
 
 
Fig. 2 NAP Plate - Coagulase  Negative  Staphylococcus (CONS). 
 
 Fig.3 TUBE COAGULASE TEST 
 
 
Fig. 4 ANTIBIOGRAM 
 
  
 
 
 
 
 
 
Fig.5 Erythromycin sensitive pattern 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig.6 Erythromycin resistance MLSB penotypes 
Fig.6.1 Inducible MLSB phenotype (iMLSB ) 
 
Fig. 6.2 Constitutive MLSB phenotype (cMLSB) 
 
Fig. 6.3 MS phenotype 
 
 
  
Fig. 7 MRSA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 8 D- Test  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 PCR - DNA extraction kit 
 
 
 
 
Fig. 10 PCR amplification kit 
 
 
Fig. 11 DNA extraction 
 
 
 
 
 
 
Fig. 12 Centrifuge 
 
 
Fig. 13 Vortex mixer 
 
 
 
Fig. 14 Thermo cycler (Biorad CFX 96) 
 
 
 
 
 
 
Fig.15 PCR Graph 1 
 
 
 
Fig.16 PCR Graph 2
 
Fig.17 PCR Graph 3
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                                                 5. RESULTS 
 
The  study  was  conducted  in  the  Department  of  Microbiology,  
Tirunelveli   Medical  College,   Tirunelveli , during  the  period  April  2013  
to May 2014. Clinical  samples  of  sample  size -100  Staphylococcal  isolates   
which was isolated   from the collected  samples from  out-patient and  
hospitalised patients  of  various  departments. 
The Staphylococcal  strains  isolated  from  the  study  samples were   
80%  Staphylococcus  aureus  and  20 %  CONS.  These   isolates   were  
processed  and  further  tested for antibiotic   sensitivity  patterns .They  were  
screened for   Methicillin  sensitivity  pattern  by  Cefoxitin   disc  method and  
inducible    Clindamycin  resistance  pattern by D-test.   
D-test   was   used   to screen clinical   isolates  of   Staphylococci 
which  were  erythromycin-resistant  for  resistance to Macrolides, 
Lincosamides  and   Streptogramins  (MLSB) which  may be constitutive 
(MLSBc) inducible (MLSBi)  or  MS phenotype . The erythromycin  
ribosome  methylase (erm)  genes responsible  for  this  resistance   among  
inducible  Clindamycin  resistance (MLSBi)   pattern  was detected  by 
Real-Time PCR  and  was  further analysed. 
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Statistical Analysis : 
Data   regarding   the   subjects   were   described   in   terms  of  
percentages. The   ages  of  the  subjects  were  compared  between  the  
genders by percentages .Statistical  software   IBM  SPSS  statistics 20 was  
used  for  the  statistical  procedures .  The (P <0.05)   was   considered  as  
significant in Chi  square  and  Fisher  exact  test. 
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Table   4: Distribution  of  Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus. 
 
 The Staphylococcal  strains  isolated  from  the  study  samples were   80%  
Staphylococcus  aureus  and  20 %  CONS   (Table-1) 
 
 
 
 
 
 
 
Total  Staphylococcal  
isolates 
Staphylococcus  aureus Coagulase   Negative 
Staphylococcus. 
100 80 20 
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Figure 18:  Distribution  of  Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus.  
.  
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Table  5 : Age-sex  wise  distribution  of  the  study  group. 
           
          AGE 
    
        MALE 
    
     FEMALE 
          0-10       3(5.46%)     2(4.45%) 
         11-20       4(7.28%)      2(4.45%) 
         21-30       15(27.28%)      9(20%) 
         31-40       14(25.45%)      9(20%) 
         41-50        6(10.90%)      10(22.22%) 
         51-60        7(12.72%)       9(20%) 
         >60        6(10.90%)       4(8.88%) 
       TOTAL       55(100%)       45(100%) 
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     Majority of   the  study  group  were  found to  be among the  age  group     
21-30 yrs. The   Male to female  sex  ratio  was  1.22 :1 .  Chi square P-
value was  0.657  and  statistically  found  not  significant. There was no 
association between age group and gender wise distribution. 
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Figure  19 : Age-sex  wise  distribution  of  the  study  group. 
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Table  6: Distribution  of  Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus  among  samples. 
Samples 
Staphylococcus  
aureus   
    
Coagulase  
Negative  
Staphylococcus 
Pus 60(75%) 20(100%) 
Wound swab 8(10%) 0 
Aural swab 8(10%) 0 
Vaginal swab 4(5%) 0 
Total 80(100%) 20(100%) 
 
 
 
 
 
56 
 
 
 
Among  the clinical  samples collected  80%  were  pus, 8% wound  
swabs, 8%  aural  swabs  and  4% vaginal  swabs.  Majority   of  the  
Staphylococcus .aureus about  75%  and CONS  100%   were isolated  from  
pus. 
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Figure   20 : Distribution  of  Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus  among  samples. 
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Table 7: Distribution of Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus. 
 
 
 
 
 
 
 
 
 
 
 
Staphylococcal         
isolates 
Out  patient  
department(OPD) 
In  patient  
department(IPD) 
 
        S.aureus              
 
         16(80%) 
 
       64(80%)   
 
         CONS 
 
          4(20%)    
 
        16(20%) 
 
           TOTAL 
 
           20 
 
          80 
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Among  the  Staphylococcal  isolates  80%  were  Staphylococcus  
aureus  and  20%  were  Coagulase  Negative  Staphylococcus .  
Staphylococcus aureus  was  found  pronounced  than  CONS  in  both  OPD  
and  IPD  patients.  Fisher‘s Exact   p value was 1.00. There was no 
significant association between Staphylococcal   isolates and hospitalization 
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Figure   21 : Distribution  of  Staphylococcus  aureus  and  Coagulase  
Negative  Staphylococcus. 
.
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The  staphylococcal  isolates  was  found  to  be  distributed  about  
80%  in  samples  collected   in  in-patient  department  and  20%  among  
out  - patient department.  
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Table  8 : Antibiotic  resistance  among   Staphylococcal  isolates. 
 
Antibiotics 
           
Staphylococcus 
aureus 
 
  Coagulase  
Negative  
Staphylococcus        
    
         Total 
Ampicillin           35(87.5%)        5(12.55%) 40 
Amoxy clav           38(77.55%)       11(22.45%) 49 
Doxycyclin           34(82.93%)        7(17.07%) 41 
Ciprofloxacin           31(75.60%)        6(14.63%) 41 
Cotrimoxazole           24(80%)         6(20%) 30 
Gentamycin           26(78.79%)        7(21.21%) 33 
Cefoxitin           25(83.33%)        5(16.67%) 30 
Erythromycin           34(80.95%)        8(19.05%) 42 
Clindamycin            4(80%)        1(20%) 5 
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The  antibiotic  resistance  among  Staphylococcus aureus  were 
found to be 87.5% Ampicillin%,77.55%Amoxyclav, 82.93%  Doxycyclin, 
75.6 % Ciprofloxacin,  80%  Cotrimoxazole ,  78.79% Gentamycin  83.33% 
Cefoxitin  80.95% Erythromycin  and  80% Clindamycin. 
The  antibiotic  resistance  pattern   among  CONS  were  12.55% 
Ampicillin, 22.45% Amoxy clav, 17.07% Doxycyclin,14.63 % 
Ciprofloxacin, 20%  Cotrimoxazole and 21.21%  Gentamycin,16.67% 
Cefoxitin 19.05% ,Erythromycin   and  20%  Clindamycin.   Chi square  P-
value  <  0.001 was  found  statistically  significant. There   was an 
association between antibiotic  resistance with staphylococcal isolates. 
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Figure  22 : Antibiotic  resistance  among   Staphylococcal  isolates. 
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Table   9 : Distribution  of   Staphylococcal   strains  among   OPD/IPD 
patients. 
 
 
 
 
 
 
 
 
Staphylococcal 
 isolates 
 
MSSA 
 
MRSA 
 
MSCONS 
 
MRCONS 
 
Total 
 
Out patient  
department 
 
10 
(50%) 
 
6 
(30%) 
 
4 
(20%) 
 
0 
 
20 
 
In patient department 
 
45 
(56.25%) 
 
19 
(23.75%) 
 
11 
(13.75%) 
 
5 
(6.25%) 
 
80 
 
Total 
 
55 
 
25 
 
15 
 
5 
 
100 
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Among  the  Staphylococcal  isolates  obtained  from  out - patient 
department 50%  were  MSSA, 30%  MRSA and  20%  MSCONS.  Samples   
from   In-patient department   showed 56.25 %   MSSA, 23.75%  MRSA, 
13.75%  MSCONS  and   6.25 % MRCONS. . The  Fishers  Exact  P-value   
was   0.546 .This   was  not   statistically  significant. There  was no  
association between  the  distribution  of staphylococcal isolates  among  the  
OPD/IPD  patients. 
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Figure 23  : Distribution  of   Staphylococcal   strains  among   OPD/IPD 
patients. 
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Table  10: Distribution  of   MSSA  , MRSA, MSCONS, MRCONS 
among clinical  samples. 
Samples MSSA MRSA 
 
MSCONS 
 
MRCONS 
 
Total 
Pus 42(52.5%) 18(22.5%) 15(18.75%) 5(6.25%) 80 
Wound 
swab 
5(62.5%) 3(37.5%) 
0 
0 
8 
Aural  
swab 
6(75%) 2(25%) 
0 
0 
8 
Vaginal 
swab 
2(50%) 2(50%) 
0 
0 
4 
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                 During   the   study    100  Staphylococcal  strains  were  isolated   
from  clinical  samples  collected  from various  departments which  
included  80  pus  samples,  8  wound  swabs,  8  aural   swabs  and   4  
vaginal swabs.  The   majority   of   the   samples collected  from various 
wards  were  from pus ( 80%).Among  the  pus  samples  MSSA  were  
52.5%,MRSA (22.5%) MSCONS (18.75%)   and   MRCONS  (6.25%).MSSA 
The  chi-square   P-value   was   0.804 .This  was  not  found   to   be  
statistically  significant. There  was no  association  between  the  
distribution  of staphylococcal isolates  among  the samples  
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Figure 24 : Distribution  of   MSSA  , MRSA, MSCONS, MRCONS 
among clinical  samples . 
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Table 11: Phenotypic distribution of  iMLSB , cMLSB  &MSP among    
Erythromycin  resistant  isolates. 
                      
 
                      Phenotypes 
 
               Number 
                        iMLSB                 14(35%) 
                        cMLSB                  5(12.5%) 
                          MS                  21(52.5%) 
Total  Erythromycin  resistant 
isolates 
                 40 
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Out  of   the  40  Erythromycin  resistant  isolates   based  on  D-test   
the  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  were  35%, 
12.5%  and 52.5%  respectively. 
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Figure  25 : Phenotypic distribution of  iMLSB , cMLSB  &MSP among    
Erythromycin  resistant  isolates 
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Table   12   : Distribution  of   iMLSB , cMLSB AND  MS  phenotypes   
among  samples . 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Samples iMLSB cMLSB     MSP 
Pus 9(64.28%) 3(60%) 17(80.95%) 
Wound swab 3(21.43%) 0 0 
Aural swab 1(7.14%) 0 3(14.95%) 
Vaginal swab 1(7.14%) 2(40%) 1(4.76%) 
Total 14 5 21 
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The  distribution  of  iMLSB  phenotype  among  samples  were 
found  to  be   pus  64.29%,   wound  swabs  21.43%,   aural  swabs 7.14%   
and  vaginal  swabs 7.14%.The  distribution  of  cMLSB  phenotype  among  
samples  were  pus  60%, and  vaginal  swabs  40%.  The  distribution  of  
MS  phenotype  among  samples  were  pus  80.95% , aural   swabs 14 .29 
% and  vaginal  swabs  4 .76 %.   The  chi-square   P-value   was   0.05 .This   
was  found   statistically  significant. There  was   association between  the   
phenotypic  distribution   and   the  samples. 
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Figure  26 : Distribution  of   iMLSB , cMLSB AND  MS  phenotype   
among  samples . 
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Table  13 :Phenotypic distribution of  iMLSB , cMLSB  &MSP among  
Staphylococcal   isolates. 
 
Phenotype S.aureus CONS 
iMLSB 12(37.5%) 2(25%) 
cMLSB 4(12.5%) 1(12.5%) 
MSP 16(50%) 5(62.5%) 
 32 8 
 
The  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  among  
S.aureus  were  37.5%, 12.5%, , 50%   and  CONS     25%, 12.5%, 62.5%   
respectively.  
 P-value  0.473 fe  found  not  significant. 
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Figure 27 : Phenotypic distribution of  iMLSB , cMLSB  &MSP among  
Staphylococcal   isolates. 
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Table  14:  The  relation  of  MSSA, MRSA  ,MSCONS, MRCONS  IN  
MLSB   PHENOTYPES. 
MLSB 
Type 
MSSA MRSA MSCONS MRCONS Total 
iMLSB 6(42.85%) 6(42.85%) 0 2(14.28%)       14 
cMLSB 3(60%) 1(20%) 1(20%) 0       5 
MS 10(47.61%) 6(28.57%) 2(9.52%) 3(14.28%)       21 
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The  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  among  
MSSA were  42.85%, 60%, ,47.61%   and     MRSA  42.85%, 20%, 28.57%   
respectively 
The  phenotypic  distribution  of   cMLSB   and  MS  among  
MSCONS were  20%, 9.52%   .The  distribution  of   iMLSB   and MS  
phenotype  among MRCONS  were  14.28%  and  14.28%   respectively 
 
 
. 
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Figure  28 :  The  relation  of  MSSA, MRSA  ,MSCONS, MRCONS  IN  
MLSB   PHENOTYPES. 
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Table 15: Comparison  of  antibiotic  resistance  among   iMLSB , 
cMLSB,MS  phenotypes.  
 
Antibiotics 
iMLSB cMLSB MS  
Ampicillin    13(32.5%)        2(5%) 7(17.5%) 
Amoxy clav    13(26.53%)        2(4.08%) 9(18.36%) 
Doxycyclin     8(19.51%)        2(4.87%) 6(14.63%) 
Ciprofloxacin     4(9.75%)        3(7.31%) 10(24.39%) 
Cotrimoxazole     5(16.66%)        1(3.33%) 7(23.33%) 
Gentamycin     6(18.18%)        0 4(12.12%) 
Cefoxitin     6(20%)        1(3.33%) 9(30%) 
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Among  iMLSB phenotype  antibiotic resistance  were  found   in 
32.5% Ampicillin,26.53% Amoxyclav,19.51% Doxycyclin,9.75% 
Ciprofloxacin,16.66% Cotrimoxazole , 18.18% Gentamycin and Cefoxitin 
20%..Among cMLSB   phenotype antibiotic  resistance  pattern  were 5% 
Ampicillin,4.08 % Amoxy clav 4.87% Doxycyclin,7.31% Ciprofloxacin, 
3.33%  cotrimoxazole and 3.33%  Cefoxitin.  Chi-square   P-value   was   
0.677 .This  was found not  statistically  significant. There   was   no   
association   between  the   antibiotic resistance   and   the  different  
phenotypic  isolates. 
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Figure 29 : Comparison  of  antibiotic  resistance  among   iMLSB , 
cMLSB, MS phenotypes. 
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Table 16: Distribution of   erm GENE IN  Real Time  PCR  among  
inducible MLSB  (iMLSB )  phenotype. 
 
Genotype-PCR   Number               Percentage 
erm A  only         3                      21.42 
erm B   only         1                       7.14 
erm C   only         2                       14.3 
erm A & erm C         7                        50 
erm B & erm C         1                       7.14 
Total         14                        100 
 
Real  time  PCR  detected  21.42% erm A,7.14% erm B,14.3% erm C,50% 
both erm A and  erm C  and  7.14%  both  erm B  and  erm C  among  the  
inducible  MLSB (iMLSB) phenotype . 
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Figure 30 : Distribution  of   erm gene  among   iMLSB phenotype    
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Table 17: Distribution  of   erm gene  among   Staphylococcal  isolates.   
Staphylococcal 
isolates 
Staphylococcus aureus Coagulase Negative 
Staphyloccus 
iMLSB MSSA MRSA MSCONS MRCONS 
erm A 1(16.66%)  2(33.33%)           0            0 
erm B       0 1(16.66%)           0            0 
erm C 1(16.66%) 1(16.66%)           0            0 
ermA  &erm C 4(66.66%) 2(33.33%)           0 1(50%) 
erm B &ermC       0         0           0 1(50%) 
Total       6         6           0            2 
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Among  erm A 16.66% were  MSSA  and  33.33%  MRSA. In  erm B 
16.66% were  MRSA , erm C was  expressed  among  16.66%- MSSA and 
16.66%-MRSA. Both erm A & erm C  were  expressed  in  66.66% MSSA 
,33.33% MRSA  and  50% MRCONS . Both  erm B & erm C were  
expressed  in 50% of  MRCONS.  
Chi-square   P-value   was   0.141 .This   was  found   not  statistically  
significant. There  was  no  association   between  the   erm  gene  
distribution   among   the  iMLSB  phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
 
Figure  31:  Distribution  of   erm gene  amongStaphylococcal  isolates   
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In   all   the  Staphylococcal   D-test  positive  inducible  Clindamycin  
resistance  (iMLSB)  phenotype    erm  gene  was  detected   by  real  time  
PCR. 
The  sensitivity  and  specificity  of  D-test  was  100%  compared  
with  the  gold  standard   PCR. 
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6. DISCUSSION 
 
Staphylococci   producing  life threatening   infections in hospital and  
in community   develops   resistance towards  antimicrobials. The  
development  of  antimicrobial resistance  towards  beta-lactam  antibiotics  
and  development  of  MRSA   has become  an increasing problem  . 
Clindamycin   is  considered  as  an  alternative drug   of  choice  with  good 
in vitro and in vivo activity
1
 
The    indiscriminate   usage of antibiotic can   be  avoided   by testing 
on  clinical isolates  the  antimicrobial  susceptibility   as empirical 
treatment with  antibiotics may lead   to   multi drug resistance  mainly  
towards  MRSA. 
5
 
Clindamycin, is an antibiotic  of choice against MRSA. Which   in the 
presence of Erythromycin  produces resistance due  to  the  induction  by  
Erythromycin.This  resistance  is  due  to   induction of cross- resistance 
between members of the Macrolide, Lincosamide, Strepto-gramin B 
(MLSB) group. The empirical  therapy  of  Staphylococcal   infections  with   
antibiotics  is  not  advisable   because  of  the  development of  MRSA  
infections  that  is  increasing  in  the  community  setting  .   The   
production of  resistance to Clindamycin   limits   the effect of this drug. 
92 
Double Disk diffusion agar inhibitory assay or D – test   is  used  to 
demonstrate  MLSBi   phenotype.
30
 
In the present study, inducible  resistance  to Clindamycin  (iMLSB)  
among    Methicilln  sensitive  as  well as resistant   Staphylococcal strains  
at our institute   was  detected  by D-test  and    erm  gene  responsible for  
iMLSB  was detected  by  real   time  PCR. 
In   the  present  study  out  of  100   Staphylococcal strains    isolated   
from  clinical  samples   from  various   patients  of  different   departments   
80%  were   Staphylococcus  aureus  and the  remaining  20%  Ccoagulase  
Negative  Staphylococcus .  
In  the  present  study  55%  were  males  and  45%  females Male  
and  female were  found  to  be  in  the   ratio  of  1.22 : 1.The gender  
association  in  this  study showed  no  association  and majority  were  
found  in  age  group  of  21-30 yrs  .                                     
In  this  study  Staphylococcal  isolates were  obtained   80%  from  
pus, 8% from wound  swab, 8%  aural  swab and  4% vaginal  swab. 
Majority   of  the  Staphylococcus  aureus   75%  and  CONS 100%   were  
isolated  from  pus. 
In  the  present  study among  the  isolated  Staphylococcal  strains  
80% were  from  hospitalized  patients  and  20%  were OPD  patients. In  
this  study  out of  the  Staphylococcal  isolates among 80% Staphylococcus  
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aureus  55%  were  MSSA    and  25% MRSA .Among  the  20% CONS   
15%  were MSCONS  and 5%  MRCONS. Samples obtained  from  OPD  
50%  were  MSSA, 30%  MRSA and  20%  MSCONS. Samples   from  IPD  
showed  56.25%  MSSA, 23.75%  MRSA, 13.75%  MSCONS  and   6.25% 
MRCONS . 
Out  of   the  40  Erythromycin  resistant  isolates   based  on  D-test   
the  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  were  35%, 
12.5%  and 52.5%  respectively 
In  a  study  by  Vidhya et  al 
42
 among the  inducible Clindamycin 
resistance (D-test positive)  was  13.33% constitutive resistance was 40% 
and MS phenotype (D-test negative) was  35.43%  
In this  study  the  distribution  of  iMLSB  phenotype  among  
samples  were  pus   64.28%, wound  swab  21.43%, aural swab 7.14% and  
vaginal  swab 7.14%.The  distribution  of  cMLSB  phenotype  among  
samples  were  pus  60%, and  vaginal  swab  40%.The  distribution  of  MS  
phenotype  among  samples  were  pus  80.95% , aural  swab 14 .95 % and  
vaginal  swab 4 .76 %.   
The  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  among  
S.aureus  were  37.5%, 12.5%, , 50%   and  CONS     25%, 12.5%, 62.5%   
respectively. Sureet  et al 
49
 showed  Staphylococcus aureus 9.9%  and  
CoNS (5.5%)  were inducible CL resistance. Matthew  et  al 
8
   in his study 
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showed  a high prevalence  (96.3%) of iMLSB resistance  among  S. aureus 
isolates . 
The  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  among  
MSSA were  42.85%, 60%, ,47.61%   and     MRSA  42.85%, 20%, 28.57%   
respectively. This  showed  that MSSA  was  found  more  among  cMLSB  
and  MRSA  among   iMLSB. 
The  phenotypic  distribution  of   cMLSB   and  MS  among  
MSCONS were  20%, 9.52% respectively  .The  distribution  of   iMLSB   
and MS  phenotype  among MRCONS  were  14.28%  and  14.28%   
respectively 
This is in concordance with few studies reported in India.  
Deotale et al
39
 found 27.6% iMLSB in MRSA and 1.6% in MSSA. 
Gupta et al showed it to be 20% in MRSA and 17.33% in MSSA. 
Prabhu et al showed 20% in MRSA and 6.15% in MSSA.   
Vidhya  et al 
42
 showed   inducible clindamycin resistance is more in 
MRSA 23.07% compared to MSSA 3.52%. 
Sureet et al 
49 
showed MRSA more  than in MSSA, 35.9% and 4.7%  
respectively in  iMLSB. 
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Matthew  et  al 
8
 showed   high rate  of  iMLSB among  both 
Methicillin sensitive  and  resistant isolates, obtained from  both  
community- and hospital-acquired infections. 
Antibiotic  sensitivity: Among  iMLSB phenotype  antibiotic 
resistance  were  found   in 32.5% Ampicillin,26.53% Amoxyclav,19.51% 
Doxycyclin,9.75% Ciprofloxacin,16.66% Cotrimoxazole , 18.18% 
Gentamycin and Cefoxitin 20%..Among cMLSB   phenotype antibiotic  
resistance  pattern  were 5% Ampicillin,4.08 % Amoxy clav 4.87% 
Doxycyclin,7.31% Ciprofloxacin, 3.33%  cotrimoxazole and 3.33%  
Cefoxitin. There   was   no   association   between  the   antibiotic resistance   
and   the  different  phenotypic  isolates. 
In  this   study  None  of  the  isolates  were  resistant  to  
Vancomycin. In  a  study by Tiwari et  al 
2
 all the iMLS phenotype B  
Staphylococcus aureus strains were sensitive to  Vancomycin and Linezolid 
(100%).                             
In   this   study   Real  time  PCR  showed  21.42% ermA,7.14% erm 
B,14.3% erm C,50% erm A and  ermC  and  7.14% ermB  and  ermC .  
Among  erm A 16.66% were  MSSA  and  33.33%  MRSA. In  erm B 
16.66% were  MRSA , erm C was  expressed  among  16.66%- MSSA and 
16.66%-MRSA. Both erm A & erm C  were  expressed  in  
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66.66%MSSA,33.33% MRSA  and  50% MRCONS .Both  erm B and  erm 
C were  expressed  in 50% of  MRCONS 
Study  by  Feibelcon  et  al 
37
 showed  S. aureus  isolates among  19  
samples with  iMLSB  for genetic analysis, 18 contained erm  A and 
remaining 1 showed   ermC.  Out  of  4  CONS    isolates showed  ; 3   ermC  
, and one contained  ermA  msrA, but not ermA or ermC  was   detected   
among Clindamycin  susceptible  isolates with  negative  test . Only one 
resistance mechanism among   the   S.  aureus isolates ;  five (6%) possessed 
an erm gene plus msrA.  12 (12%) CONS isolates  possessed two or more 
resistance genes 
Matthew  et  al 
8
 showed  out of 28   iMLSB  among  S. aureus   
isolates8  genotyped  harbored ermA, and the remainder harbored ermC 
The  observations  made  in this  study  suggest  routine  D-test  in  all  
clinical  laboratories  to  detect  inducible Clindamycin resistance when 
Staphylococcal  isolates  showed  Erythromycin  resistant  and   
Clindamycin    susceptible pattern.    Failure to identify them   lead to 
therapeutical  failure in  the  usage   of     Clindamycin   for  treatment. 
In  this  present  study    D-test is  an easy test  which can  be  
performed  in  every  laboratory . It  is  also  found  inexpensive test  which  
can  be  used  for practical purpose than PCR  which  is  the  gold  standard 
.This test can be  used to detect an inducible Clindamycin resistance in 
97 
staphylococci as a routine test  in  laboratories where  PCR  is  not  available            
This test  help  us  to provide confident  laboratory reports and Clindamycin 
can be omitted in patients with infections caused  by inducible Clindamycin  
resistance staphylococci, and therapeutic failures may be thus avoided. 
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7.  SUMMARY 
                   
                     This  study was  undertaken  in  Tirunelveli Medical  College, 
Tirunelveli   for  a period  of  one  year  from 100  Staphylococcal  isolates  
80%  were  Staphylococcus  aureus  and  rest   20%  were  coagulase  
negative staphylococcus. Out of   strains    isolated  80%  were from  
hospitalized  patients .  The  study  group  contained  55% males  and  45%  
females  and  Male   to female  sex  ratio  was  1.2 2:1. Majority  of  the  
study  group  were  found  among  the  age  group  21-30 yrs. 
Majority  of  the  Staphylococcal aureus   75%   and CONS   100%   
were  isolated  from  pus  and  majority  of  the  MSSA 76.36%  and  72% 
MRSA were    also  from  pus.   
Out  of   the  40  Erythromycin  resistant  isolates   based  on  D-test   
the  phenotypic  distribution  of  iMLSB , cMLSB   and  MS  were  35%, 
12.5%  and 52.5%  respectively 
In  the  phenotypic  distribution  of  iMLSB  Staphylococcus .aureus  
was  37.5%   and  CONS     25%,.   MSSA  31.58%  and     MRSA 46.15%.  
Majority  of  the  iMLSB  was  susceptible  to  Ciprofloxacin  
Cotrimoxazole  and   Gentamycin. while  cMLSB  and  MS  phenotype  
were  resistant  to  Ciprofloxacin when  compaired  to  iMLSB .There was  
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high  rate  of  resistance  exhibited  by  cMLSB  towards  Cefoxitin  when  
compaired  to  iMLSB.. No resistance was observed to Vancomycin. 
Genetic  analysis  by   real  time  PCR  performed  on  iMLSB   
showed  21.42% erm A,7.14% erm B,14.3% erm C,50% erm A and  ermC  
and  7.14% ermB  and  erm C.  
In   all   the  Staphylococcal   D-test  positive  inducible  Clindamycin  
resistance  (iMLSB)  phenotype    erm  gene  was  detected   by  real  time  
PCR.  The  sensitivity  and  specificity  of  D-test  was  100%  compared  
with  the  gold  standard   PCR. 
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8 . CONCLUSION 
 
 The present   study ―DETECTION  OF  erm   GENE   AMONG   
INDUCIBLE     CLINDAMYCIN    RESISTANT 
STAPHYLOCOCCAL  ISOLATES  IN  CLINICAL  SAMPLES  
‘‘ was  conducted  in  the  Department  of  Microbiology,  Tirunelveli   
Medical  College,   Tirunelveli  during  the  period  April  2013  to 
May 2014 .   
 Cefoxitin disc diffusion  test  was  used  to   detect  MRSA  and  
MSSA, which revealed among   Staphylococcal  isolates that MSSA 
was  found  pronounced  than   MRSA.  
  D-test  revealed  iMLSB   was  found  more  among  the  MRSA than    
MRSA  .   
 Majority of  the  iMLSB  was  susceptible  to  Ciprofloxacin , 
Cotrimoxazole  and   Gentamycin. while  cMLSB  and  MS  
phenotype  were  resistant  to  Ciprofloxacin when  compaired  to  
iMLSB .There was  high  rate  of  resistance  exhibited  by  cMLSB 
towards  Cefoxitin  when  compaired  to  iMLSB 
 Genetic  analysis  by   Real  time  PCR  detected  erm  gene  in  all  
iMLSB  phenotype   which  was  responsible  for  the  resistance  .  
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 Since, failure in  the therapy  with Clindamycin  used against 
Staphylococcal isolates  had been frequently met, the Inducible 
resistance due to erm gene can   be   detected  by  D-test  and  can  be  
used  as  a  routine  test   in all microbiology laboratory, which helps 
the clinicians in avoiding   treatment failure with Clindamycin. 
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ANNEXURE-I 
 ANNEXURE-I 
 
McFarland Standard (0.5) 
Composition and preparation 1 % (V/V) solution of chemically pure 
(0.36N)Sulphuric acid and 1.175 % (W/V) solution of chemically pure 
(0.048M) barium chloride was prepared in two separate sterile flasks. Then 
9.9 ml of sulphuric acid and 0.1 ml of barium chloride were added to the 
clean screw capped test tube and sealed. To make the turbidity standard of 
cell density to one half(0.5) of the McFarland standard tube No.1 which 
correspond to cell density of 1.5 × 108 organism/ml for determination of 
antibiotic sensitivity by Kirby-Bauer inoculated technique 0.5 ml of 1.7 
%(W/V) barium chloride (Bacl2 2H 2O) was added to 99.5 ml of 1 % (V/V) 
Sulphuric acid(0.36N), mixed well and 5- 10 ml was distributed in sterile 
capped test tubes and sealed. . 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
ANNEXURE-II 
 
ANNEXURE-II 
PROFORMA 
 
NAME: 
AGE: 
SEX: 
ADDRESS: 
 
 
WARD: 
IP NO: 
DATE: 
SPECIMEN: 
CLINICAL DIAGNOSIS: 
RISK FACTORS: 
1)DURATION OF HOSPITALISATION: 
2)INSTRUMENTATION: CVC/IV LINE 
3)ANTIBIOTICS ADMINISTERED: 
       a)CLASS:PENCILLINS/CEPHALOSPORINS/AMINOGLYCOSIDES 
          MACROLIDES/CARBAPENEMS. 
       b)DURATION OF ANTIBIOTICS ADMINISTERED: <7 DAYS/>7 
DAYS 
4)ANY CHRONIC DISORDERS:DM/HT/RENAL 
FAILURE/HART/OTHERS. 
5) ICU STAY :YES/NO 
 
INVESTIGATIONS 
1)SLIDE COAGULASE 
2)TUBE COAGULASE 
3)ANTIBIOGRAM:  CEFOXITIN (30µg) 
                              ERYTHROMYCIN (15µg) 
                              AMIKACIN/GENTAMYCIN(30µg) 
                              CIPROFLOXACIN(5µg) 
                              CLINDAMYCIN(2µg) 
4)D-TEST: ERYTHROMYCIN 
                 CLINDAMYCIN 
5)PCR-  erm[A], 
             erm[B], 
             erm[C]. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
ANNEXURE-III 
ANNEXURE-III 
 
Detection of erm gene among inducible Clindamycin Resistant 
Staphylococcal isolates in clinical samples  
AIM: 
The present study is aimed to detect erm gene in inducible 
Clindamycin resistant Staphylococcal  isolates and to study the relationship 
between Clindamycin and Methicillin resistance . 
MATERIALS AND METHODS: 
              A total of 100 Staphylococcal clinical isolates will be collected 
from the department of Microbiology, Tirunelveli Medical College, 
Tirunelveli. Staphylococcal isolates from pus-wound swab and aspirates 
will be identified using conventional bacteriological methods and their 
susceptibility tested by standard disk diffusion method on Muller Hinton 
agar[MHA] according to the standards of clinical and laboratory standards 
institute[CLSI].Detection of inducible Clindamycin resistence will be 
performed by D-test. The presence of methylase genes erm[A], erm[B], 
erm[C] will be determined by PCR. 
JUSTIFICATION OF THE STUDY: 
The emergence of resistance to most antimicrobial agents in 
Staphylococci indicates the need for new effective agents in the treatment of 
Staphylococcal infection. Among the alternatives available Clindamycin is 
considered to be safe, effective and less costly agent. In vitro routine tests 
for Clindamycin susceptibility may fail to detect inducible Clindamycin 
resistance due to erm genes, resulting in treatment failure, thus necessitating 
the need to detect such resistance by a simple    D-test on routine basis.  
REFERENCES: 
1. 1.R Goyal, N P Singh, V.Manchanda, M.Mathur, 
IJMM[2004]22[4]251-254 Detection of clindamycin susceptibility in 
macrolide resistant phenotype of staphylococcus aureus. 
2. 2.A.D Alek Sandra,M S Violeta, I T Pragama, B M Zoran, V.S Dejan, 
S.D Milanko, B.D Dejan  IJMM[2014]32[1]49-52 prevalence of 
inducible clindamycin resistance among community associated 
staphylococcal isolates in central Serbia. 
3. 3.V.Deotale,D.K Mendiratta, U Raut, P.Narang, 
IJMM[2010]28[2]:124-6 Inducible clindamycin resistance in 
staphyloccus aureus isolates from clinical samples. 
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1 590 IP 7 F SWAB W.INFEC 10 P P P P N N N N R R S R R S S S S S SS N N N N N
3 638 IP 20 M PUS ABSCESS 7 P P P P N N N N R R S R R R S S S S SS N N N N N
6 664 IP 40 M PUS ABSCESS 20 P P P P N N N N S S S S S S S S R D I N N P N N
10 895 IP 53 M PUS ABSCESS 7 P P P P N N N N S S S S R S S S R S MS N N N N N
12 906 IP 12 F PUS ABSCESS 8 P P P P N N N N S S S S S S S S S S SS N N N N N
13 911 IP 27 M PUS ABSCESS 10 N N N N N P N P S S S S R R R S R S MS N N N N N
14 918 IP 54 M SWAB EAR 15 P P P P N N N N R R R R S R S S R D I P N P N N
15 919 IP 8 M PUS ABSCESS 8 P P P P N N N N R R S S S R S S S S SS N N N N N
16 921 IP 29 M PUS ABSCESS 5 P P P P N N N N R R S S S S S S S S SS N N N N N
17 923 IP 55 M PUS ABSCESS 6 P P P P N N N N R R S S R R S S S S SS N N N N N
20 929 OP 28 M PUS ABSCESS 0 P P P P N N N N S S R R S R S S S S SS N N N N N
25 1269 IP 32 M PUS ABSCESS 8 P P P P N N N N S R S S S R S S R S MS N N N N N
27 1349 IP 23 M SWAB W.INFEC 15 P P P P N N N N R R S S S R S S R D I P N P N N
28 1381 IP 43 M PUS ABSCESS 5 P P P P N N N N S R R S S S S S S S SS N N N N N
35 1628 IP 33 M PUS ABSCESS 16 P P P P N N N N R R R S S S S S R D I P N P N N
36 1640 IP 28 M PUS ABSCESS 3 P P P P N N N N S S S S S S S S S S SS N N N N N
37 1659 IP 32 M PUS ABSCESS 5 P P P P N N N N R R S S S S S S S S SS N N N N N
38 1662 IP 54 M PUS ABSCESS 5 P P P P N N N N R R S S S S S S S S SS N N N N N
40 1865 IP 10 M SWAB EAR 5 P P P P N N N N S S S S S S S S S S SS N N N N N
48 2293 IP 14 M PUS ABSCESS 5 P P P P N N N N S S S R S S S S S S SS N N N N N
49 2393 IP 41 M PUS ABSCESS 8 P P P P N N N N S S R S S S S S R S MS N N N N N
50 2456 IP 22 M SWAB EAR 2 P P P P N N N N S S R S S S S S S S SS N N N N N
52 2862 IP 40 M PUS ABSCESS 7 P P P P N N N N R R S S S R S S S S SS N N N N N
54 2978 IP 43 M PUS ABSCESS 5 P P P P N N N N R R R S S R S S R S MS N N N N N
55 2992 OP 9 F PUS ABSCESS 5 P P P P N N N N S S S R R S S S R S SS N N N N N
60 3068 IP 42 M PUS ABSCESS 7 P P P P N N N N R R S S S S S S R S MS N N N N N
61 3195 IP 22 M PUS ABSCESS 14 P P P P N N N N R R R S R R S S R D I P N N N N
63 3204 IP 27 M PUS ABSCESS 5 N N N N N P P N S S R S R S S S S S SS N N N N N
67 3256 IP 32 M pus VAGINAL 8 P P P P N N N N S S S R R S S S S S SS N N N N N
69 3286 IP 56 M SWAB EAR 2 P P P P N N N N S S S S R R S S S S SS N N N N N
76 3512 OP 34 M PUS ABSCESS 8 N N N N N P P N S R R S R S S S S S SS N N N N N
78 3540 IP 58 M SWAB VAGINAL 6 P P P P N N N N S S R R S R S S S S SS N N N N N
80 3542 IP 25 M PUS ABSCESS 7 N N N N N P P N S S S S R S S S S S SS N N N N N
MASTER CHART
82 3546 OP 35 M PUS ABSCESS 5 N N N N N P P N S R R R S R S S S S SS N N N N N
83 3547 IP 15 M PUS ABSCESS 6 N N N N N P P N S R S S S R S S S S SS N N N N N
88 3641 IP 50 M PUS ABSCESS 7 P P P P N N N N S S R R R S S S S S SS N N N N N
89 3674 OP 42 M PUS ABSCESS 7 P P P P N N N N S S R S R S S S S S SS N N N N N
90 3675 IP 33 M PUS ABSCESS 6 N N N N N P P N S S S S R S S S S S SS N N N N N
95 4028 OP 16 M SWAB W.INFEC 12 P P P P N N N N R R S S R S S S R D I P N P N N
96 4178 IP 54 M SWAB EAR 3 P P P P N N N N S R S R S S S S R S MS N N N N N
98 4209 IP 8 M PUS ABSCESS 8 P P P P N N N N S S R R R S S S S S SS N N N N N
2 598 IP 29 M PUS ABSCESS 8 P P P P N N N N R R R S S S S S S S SS N N N N N
4 656 IP 32 M PUS ABSCESS 6 P P P P N N N N S S R R R R S S S S SS N N N N N
5 660 IP 30 F SWAB W.INFEC 10 P P P P N N N N S S S R S S S S S S SS N N N N N
7 892 OP 52 F PUS ABSCESS 0 P P P N P N N N R R S S S S R S S S SS N N N N N
8 893 IP 23 F PUS ABSCESS 5 N N N N N P P N S S S R R S S S R S MS N N N N N
9 894 IP 43 F PUS ABSCESS 6 N N N N N P N P R R S R S S R S R S MS N N N N N
11 897 IP 43 F PUS ABSCESS 5 P P P P N N N N S S S S S S S S S S SS N N N N N
18 924 IP 42 F PUS ABSCESS 5 P P P N P N N N S S R S R R R S S S SS N N N N N
19 927 IP 20 F PUS ABSCESS 4 P P P N P N N N R R S S R S R S S S SS N N N N N
21 931 IP 25 F SWAB EAR 3 P P P N P N N N S S R R S R R S S S SS N N N N N
22 932 OP 53 F PUS ABSCESS 0 P P P N P N N N S S R R R R R S R S MS N N N N N
23 1271 IP 62 M PUS ABSCESS 7 P P P N P N N N S S S S S R R S R S MS N N N N N
24 1273 IP 66 F PUS ABSCESS 16 P P P N P N N N R R R R S R R S R D I N N P N N
26 1284 IP 30 F SWAB W.INFEC 18 P P P N P N N N R R S S S R R S R D I P N P N N
29 1393 IP 40 M SWAB W.INFEC 7 P P P N P N N N R R R S S S R S S S SS N N N N N
30 1398 OP 40 F PUS ABSCESS 0 P P P P N N N N R R R S S R S S S S SS N N N N N
31 1434 IP 36 F PUS ABSCESS 4 P P P N P N N N S S S R R R R S R S MS N N N N N
32 1525 IP 32 F PUS ABSCESS 8 P P P P N N N N S S R R R S S S R S MS N N N N N
33 1625 IP 64 M PUS ABSCESS 6 N N N N N P P N S R R S S S S S S S SS N N N N N
34 1627 IP 52 F PUS ABSCESS 7 N N N N N P N P S R R S S R R S R S MS N N N N N
39 1763 OP 63 F PUS ABSCESS 0 P P P P N N N N R R S S S S S S S S SS N N N N N
41 1866 IP 22 M SWAB W.INFEC 4 P P P N P N N N S S S S S S R S S S SS N N N N N
42 1867 IP 25 M PUS ABSCESS 4 P P P N P N N N S S S S S S R S R S MS N N N N N
43 1881 IP 43 F PUS ABSCESS 17 P P P N P N N N R R R R S S R S R D I P N P N N
44 1886 IP 62 F PUS ABSCESS 4 P P P N P N N N R R S S S S R S S S SS N N N N N
45 1893 IP 44 F PUS ABSCESS 6 P P P P N N N N R R S S R R S S R S MS N N N N N
46 1956 OP 35 F PUS ABSCESS 4 P P P P N N N N R R R S R R S S S S SS N N N N N
47 1909 IP 38 M PUS ABSCESS 7 P P P P N N N N S S R S R S S S S S SS N N N N N
51 2678 OP 28 F SWAB W.INFEC 3 P P P P N N N N S S R S S S S S S S SS N N N N N
53 2948 IP 56 F SWAB VAGINAL 9 P P P N P N N N R R R S S S R S R R C N N N N N
56 3013 IP 53 F PUS ABSCESS 6 P P P P N N N N S S S R R S S S R S SS N N N N N
57 3023 IP 42 F PUS ABSCESS 5 P P P P N N N N R S R S R R S S R S MS N N N N N
58 3031 IP 22 M PUS ABSCESS 6 P P P P N N N N S S S R R S S S S S SS N N N N N
59 3067 IP 46 F PUS ABSCESS 7 P P P N P N N N R R S R S R R S S S SS N N N N N
62 3200 IP 26 F PUS ABSCESS 6 P P P P N N N N R R S S R S S S R R C N N N N N
64 3216 IP 33 M PUS ABSCESS 5 P P P P N N N N S S R S R S S S S S SS N N N N N
65 3217 OP 38 F PUS ABSCESS 4 N N N N N P P N S S S S S R S S S S SS N N N N N
66 3254 IP 62 M PUS ABSCESS 6 N N N N N P N P R R R R S R R S R D I N P P N N
68 3280 IP 63 M PUS VAGINAL 7 P P P N P N N N S S S R R S R S R S MS N N N N N
70 3318 IP 43 F PUS ABSCESS 6 N N N N N P P N S S S S R R S S S S SS N N N N N
71 3347 OP 23 M SWAB VAGINAL 15 P P P N P N N N R R R S S S R S R D I P N N N N
72 3417 IP 34 F PUS ABSCESS 7 N N N N N P P N S S R R R S S S R R C N N N N N
73 3418 IP 54 F PUS ABSCESS 16 P P P N P N N N R R R S S S R S R D I N P N N N
74 3499 IP 50 F PUS ABSCESS 7 N N N N N P P N R R S S S S S S R S MS N N N N N
75 3505 IP 38 F PUS ABSCESS 3 N N N N N P P N R R S S R S S S S S SS N N N N N
77 3529 IP 42 F SWAB EAR 3 P P P N P N N N S S R R S S R S S S SS N N N N N
79 3541 IP 23 M PUS W.INFEC 8 P P P N P N N N S S R S R R R S S S SS N N N N N
81 3543 IP 36 F PUS ABSCESS 5 N N N N N P P N S S S S S S S S S S SS N N N N N
84 3617 IP 60 F PUS ABSCESS 7 N N N N N P N P R R S R R S R S R D I P N P N N
85 3621 IP 57 F SWAB EAR 4 P P P P N N N N R R S S R S S S R S MS N N N N N
86 3624 OP 66 M PUS ABSCESS 7 P P P N P N N N S S S S S S R S R S MS N N N N N
87 3627 OP 62 M SWAB VAGINAL 6 P P P P N N N N S S S S S S S S R R C N N N N N
91 3677 OP 38 F PUS ABSCESS 4 N N N N N P P N S R S S S S S S S S SS N N N N N
92 3681 IP 26 F PUS ABSCESS 4 P P P P N N N N S R S S S S S S S S SS N N N N N
93 3728 OP 29 F PUS ABSCESS 14 P P P N P N N N R R S S R S R S R D I P N N N N
94 3879 IP 30 F PUS VAGINAL 7 P P P P N N N N S S R S S S S S S S SS N N N N N
97 4208 OP 64 F PUS ABSCESS 3 P P P P N N N N S S S S S S S S R R C N N N N N
99 4256 OP 57 F PUS ABSCESS 7 P P P N P N N N S S R S S S R S S S SS N N N N N
100 4268 IP 38 M PUS ABSCESS 8 P P P N P N N N S S S S R S R S S S SS N N N N N
